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Body of Abstract
Stroke continues to be a leading cause of disability. Many individuals who suffer
a stroke will receive specialized rehabilitation designed to maximize recovery and
restore independence with daily activities. Yet, recovery is still highly variable
with heterogeneity in treatment response that is still poorly understood. In recent
years, the growing burden of stroke has pushed for moving away from a “one
size fits all” approach with the concept of precision or personalized rehabilitation
to generate evidence for clinicians to provide the right care, to the right patient, at
the right time. The collection of research in this dissertation addresses key areas
of personalized rehabilitation related to standardized outcome measurement,
identification of biomarkers, and individualized response to treatment parameters
in three parts. Part I illustrates how principals of item response theory can be
used to inform a personalized measurement approach through clinical
applications of Rasch analysis. Part II demonstrates how muscle coordination is
linked with biomechanical variables of walking performance that can be used as
potential biomarkers of recovery. Lastly, Part III shows how interindividual
differences in treatment response could inform individualized prescription for
transcranial direct stimulation for recovery of walking post-stroke as an example
of how to approach personalized rehabilitation.
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CHAPTER 1
INTRODUCTION

1.1 INTRODUCTION TO THE PROBLEM
Unfortunately, over two thirds of individuals who suffer a stroke will not
make a full recovery (Wade, Langton-Hewer, Wood, Skilbeck, & Ismail, 1983).
Stroke continues to be a leading cause of disability with 80% of stroke survivors
have lasting sensorimotor deficits (Wade et al., 1983) and 50% not returning to
community levels of ambulation (Perry, Garrett, Gronley, & Mulroy, 1995) in the
United States. In the United States approximately 610,000 individuals will suffer a
stroke for the first time next year (Benjamin et al., 2018) and many of them will
receive specialized rehabilitation services designed to restore home and
community independence (Winstein et al., 2016).
Yet, despite advances in stroke rehabilitation care, recovery is highly
heterogeneous and interindividual variability in treatment response remains
poorly understood (Bernhardt et al., 2017). Stroke is unique in this problem
because of innate heterogeneity in the pathological presentation of the disease.
Stroke rehabilitation research and clinical practice have often used a “one size
fits all” approach because there is a lack of evidence that addresses
interindividual variability (Cramer et al., 2017). Addressing interindividual
variability should provide researchers and clinicians with evidence
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for administering individuals the right treatment at the right time to improve
outcomes, otherwise known as precision or personalized rehabilitation.
The emphasis on personalized rehabilitation has increased in response to
the growing burden stroke has placed on the United States. In 2016, the National
Institute of Neurological Disorders and Stroke (NINDS) formed the National
Institutes of Health (NIH) StrokeNet to develop a strategic plan for advancing
personalization of stroke rehabilitation. The group presented the need for
characterizing interindividual differences with respect to treatment response as
one of the key specific issues to address. They list potential sources of
interindividual differences including variation in (1) neural injury and clinical
presentation, (2) treatment response, and (3) time since initial injury in regard to
natural recovery and neural plasticity. In response to these sources of variation,
the group stressed the need for research to (1) advance the use of standardized
outcome measures, (2) identify of biomarkers or phenotypes to best inform
subgrouping individuals, and (3) evaluate individual or subgroup response to
treatments (Cramer et al., 2017).
The overarching goal of this dissertation is to address each of these three

needs to generate evidence for personalized stroke rehabilitation in research and
clinical practice. The dissertation is broken into three parts, with each part
addressing an identified research area and subsequent specific aims.
Part I addresses standardized outcome measurement. Part I examines
how item-level psychometrics and clinical applications of item response theory
can allow standardized outcome measures in stroke rehabilitation to be used to
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inform personalized clinical decision making. Part II addresses the need to
identify biomarkers. Part II will examine whether biomechanical variables of
walking performance can serve as a biomarker for impairments to walkingspecific motor control which is directly linked to neural damage. Part III will
address individual treatment response and examining whether there is
interindividual response to different prescriptions of non-invasive brain
stimulation.

1.2 RESEARCH AIMS
Part I: Item Response Theory and Clinical Measurement
The primary goal for Part I of the dissertation is to analyze two common
standardized measures in stroke rehabilitation using item response theory and
present the benefits of individual-level measurement data. Specifically, Part I will
use the Rasch model to derive item-level psychometrics and item difficulty
hierarchies for the Activities-specific Balance Confidence Scale (ABC) and the
Functional Gait Assessment (FGA). Part I will demonstrate the benefit of using
item-level psychometrics for personalization of treatment planning (FGA ability
map demonstration) and deriving patient specific change scores (ABC scale
conditional minimal detectable change demonstration).

Aim 1: Evaluate item-level psychometrics for a patient-reported (the
Activities-specific Balance Confidence Scale) and clinician-observed (the
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Functional Gait Assessment) outcome measure commonly used in stroke
rehabilitation.

Aim 2: Demonstrate how item-level psychometrics can be used to inform
personalized treatment planning using an ability map with the Functional
Gait Assessment.

Aim 3: Demonstrate how item-level psychometrics can be used to derive
change scores using individual-level patient data with the Activitiesspecific Balance Confidence Scale.

Part II: Searching for Biomarkers to Inform Patient Subgroups
The primary goal for Part II of the dissertation is to evaluate the potential for
biomechanical variables to serve as a biomarker for stroke rehabilitation of
walking-specific motor control impairments. Part II will quantify the association
between walking-specific motor control and biomechanical variables of walking
performance in healthy individuals. Understanding the association in healthy
individuals will help inform data reduction techniques to identify which
biomechanical variables have the strongest ability to serve as a biomarker. This
information can then be used to inform personalized treatments to address
biomechanical deficits that impact underlying deficits to motor control caused by
the stroke.
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Aim 1: Quantify the association between walking-specific motor control
and quantifiable biomechanical variables during steady-state self-selected
walking for healthy individuals.

Part III: Evaluating Treatment Prescription
The primary goal for Part III of the dissertation is to demonstrate a framework for
examining the effects of manipulating available parameters for an intervention on
patient specific impairments. Part III will specifically examine the effects of
manipulating tDCS electrode montage on walking-specific motor control during
post-stroke walking.

Aim 1: Determine whether electrode montage type acutely influences
walking performance.
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CHAPTER 2
LITERATURE REVIEW

2.1 BACKGROUND
This chapter will review the scientific literature relative to each part of the
dissertation including topics related to measurement theory, measurement of
walking-specific motor control and mechanics, and transcranial direct current
stimulation (tDCS) prescription and treatment effects. Knowledge gaps and
research needs are identified throughout this chapter.

2.2 MEASUREMENT THEORY:
Classical Test Theory and Item Response Theory
Standardized outcome measures in rehabilitation are primarily patientreported or clinician-observed tools. Traditionally, these types of measurement
tools have been informed by classical test theory. Classical test theory is used to
derive a model for test score into (1) the true score and (2) error (Albano, 2016).
The relative simplicity of this model supports why it has been the primary choice
for examining a tool’s measurement properties and deriving psychometrics.
However, the relative simplicity of the model is also its primary limitation;
psychometrics are sample and test dependent (Albano, 2016). Sample and test
dependency lack an overall ability estimate (a measure of the underlying
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construct of interest) and score interpretations are not always generalizable
across samples. Another limitation of classical test theory is the reliance on
group-level data for generating error estimates. Group-level data assumes that
error is the same across a measurement scale and limits the interpretability of
individual-level data. The limitations of classical test theory have some distinct
implications in research and clinical practice. The first, is that individual scores
are difficult to interpret and often lack meaning for informing decision making
(Haley & Fragala-Pinkham, 2006; Velozo & Woodbury, 2011). The second, is
that group-level data error estimates may cause misinterpretation of individuallevel measures, especially when assessing for change (Haley & FragalaPinkham, 2006; Kozlowski, Cella, Nitsch, Heinemann, & Rehabilitation, 2016;
Paul W. Stratford et al., 1996). These implications are likely the reason that
implementation of standardized outcome measures in physical therapy have
been met with several barriers. For example, physical therapists have cited
concerns about time (administration time is lengthy, requires more time than
information is worth), lack of clinically relevant information (information is too
subjective, items are not relevant to the patient), and limited interpretability
(difficult to interpret, does not contribute to the plan of care) as barriers to
measurement use (Jette, Halbert, Iverson, Miceli, & Shah, 2009; J. G. Stevens &
Beurskens, 2010). These barriers may be addressed by another approach to
examining test psychometrics, item response theory.
Item response theory places a focus on individual items in contrast to the
overall score (Velozo & Woodbury, 2011). Item response theory fits statistical
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models to response data for estimating parameters that represent the relative
locations of persons and items on the continuum of a latent ability (Thissen &
Wainer, 2001). These statistical models generate an item difficulty hierarchy that
can be used to assess the clinical and theoretical validity of the instrument.
Compared to classical test theory, item response theory attempts to measure the
person’s ability level relative to item difficulty. This approach generates an ability
estimate that is sample and test independent (Velozo, Kielhofner, & Lai, 1999).
Item response theory models also generate item level psychometrics and
measure-level error estimates (Kozlowski et al., 2016). These two benefits of
item response theory may be useful for providing meaning to individual-level
scores and allow individual-level data to be the primary source of decision
making. These benefits may also address many of the barriers listed by physical
therapists preventing standardized measurement use by addressing the
limitations of classical test theory.

The Rasch Model
The Rasch model is a one parameter logistic model and the simplest of
item response theory models (Bond & Fox, 2015). The model is based on a
probabilistic relationship between item difficulty and person ability. Persons
should have a higher probability of passing items that are easier than their ability
level and a lower probability of passing items that are harder. Persons should
also have about a 50/50 chance of passing items that are at their difficulty level.
The Rasch model examines the fit of individual’s response data to generate an

9
item difficulty hierarchy against the distribution of individual’s ability level on an
interval logit scale. Fit statistics are used to understand how well items and
persons fit the Rasch model and whether items overlap in their difficulty.
The Rasch model has two key assumptions that need to be evaluated.
The first is that the scale is unidimensional, meaning that the scale is only
measuring one construct. The second, is that the scale uses an ordered rating
scale. Factor analysis methods can be used to test and explore for additional
constructs (Reeve et al., 2007) and fit statistics from the Rasch analysis can be
used to evaluate the rating scale structure (J.M. Linacre, 2003), as well as test
the implications for misfitting persons or items (Wright & Linacre, 1994).

Applications of the Rasch Model and Connections with Personalized
Rehabilitation
The ability of the Rasch model to generate an item difficulty hierarchy,
interval measure scale, and measure-level error estimates has broad implications
for how to approach standardized measurement in research and clinical use. We
explore two applications, keyforms and conditional minimal detectable change,
that have direct implications for personalized rehabilitation and may address
many barriers limiting standardize measurement use.

Keyforms
Item difficulty hierarchies have provided a means for examining the validity
of a scale against theoretical and clinical expectations, but they also give
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understanding for how individuals may move along a construct’s continuum
(Haley & Fragala-Pinkham, 2006). Measures from the Rasch model correspond
with this continuum and can give meaning to an individual’s score. Typically, the
relationship of item difficulty to ability level is visually presented using an itemperson map, also called a Wright Map. Item-person maps have different varieties
but generally present the distribution of person ability against item difficulty on
the measure scale. These maps are ideal for examining how well the item
difficulty hierarchy matches the underlying construct and understanding how
much of the ability is captured by the overall scale. However, these maps do not
provide information with respect to a specific individual. Linacre et. al. introduced
the keyform to address this need (J. M. Linacre, 1997).
Initially, the keyform was developed to provide a way for clinicians or
researchers to generate instantaneous measure values using the Rasch
informed scale (Kielhofner, Dobria, Forsyth, & Basu, 2005; J. M. Linacre, 1997).
Keyforms are generated from the Rasch analysis and show the item hierarchy on
the left vertical axis with items progressing from easiest to hardest with the
easiest item on the bottom. Items are clustered together by difficulty level and
these clusters are separated by a blank horizontal space. Each row extending
horizontally from an item contains each of the available categories on the rating
scale. The x-axis shows the interval measurement scale. Raters can use
keyforms by circling the persons score on each item and then drawing a vertical
line “through” the bulk of the circles (J. M. Linacre, 1997). The point where the
line intersects the x-axis is an estimate of the person’s measure. Hence the idea

11
of spontaneous measurement. However, keyforms can also provide an ability
map for understanding a person’s measure with respect to their ability along the
latent construct (Grattan, Velozo, Skidmore, Page, & Woodbury, 2019; Velozo &
Woodbury, 2011; Woodbury et al., 2016).
The concept of an ability map was presented by Haley et. al. in 2006
(Haley & Fragala-Pinkham, 2006) and built upon by others (Grattan et al., 2019;
Velozo & Woodbury, 2011; Woodbury et al., 2016). Keyforms show two key
pieces of information about an individual: their measure, and their response
pattern to items. A rater can look at a keyform and instantly see how an
individual’s measure corresponds to their ability (i.e., response pattern) with
respect to the items’ difficulties. This representation can be thought of as the
ability map. In rehabilitation, this type of map is important for personalization
because the ability map can show how someone should progress along the
construct of interest’s continuum with respect to their current ability. Thus,
individual measure values have meaning with respect to a person’s ability level
and with respect to how they should progress over time. Items at the person’s
ability level reflect tasks that are representative of their current place on the
continuum and could be thought of as the “just right challenge” for an individual.
Similarly, items that are harder for an individual can be used to set goals for
rehabilitation and recovery (Grattan et al., 2019; Velozo & Woodbury, 2011;
Woodbury et al., 2016). This approach to measurement informs how to interpret
measured values for personalizing rehabilitation decision making, treatment
design, and care plans.
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Conditional Minimal Detectable Change
Error estimates are important for understanding the amount of error
associated with a person’s score, but they also are critical for identifying change.
Historically, error estimates from classical test theory were used to calculate a
minimal detectable change (MDC) threshold. MDCs are often presented with a
confidence interval and represent the amount of change necessary to exceed the
measurement error of the scale (Riddle & Stratford, 2013; Paul W. Stratford et
al., 1996; P. W. Stratford & Binkley, 1999). MDCs are used by researchers and
clinicians for classifying individuals as having a detectable change for pre- and
post-tests. However, there are some key limitations to the MDC approach.
One limitation is that MDCs rely on a single error estimates derived from
classical test theory which is problematic because of the concerns presented
earlier regarding classical test theory. First, MDCs are derived using a single
error estimate that is assumed to be stable across all measures on a scale.
However, statistically, we know that this isn’t the case and that error changes
across a measurement scale with more error being associated with extreme ends
and less error at the midrange of a scale (J. M. Linacre, 2007). The idea that
different measures have different amounts of error was recognized by Stratford
et. al. when introducing the MDC concept for physical therapists but the single
error estimate was preferred because it was less computationally intensive under
classical test theory (Paul W. Stratford et al., 1996). Second, MDC’s are sample
and test dependent. Thus, MDC’s have limited generalizability to persons with
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characteristics that do not match the sample characteristics from which the MDC
value was generated.
The next limitation is the violation of mathematical principles used to
calculate MDC’s when scales are ordinal. There has been criticism of the MDC
approach because ordinal data summarized with mean and standard deviation
statistics is not ideal from a pure mathematical standpoint (Anselmi, Vidotto,
Bettinardi, & Bertolotti, 2015; Caronni, Picardi, Gilardone, & Corbo, 2021; Kahler,
Rogausch, Brunner, & Himmel, 2008; S. S. Stevens, 1946). Since many
rehabilitation standardized outcome measures that are patient-reported or
clinician-observed often rely on ordinal scales many would argue that MDCs
should not be used for these tools.
The Rasch model is able to generate measure-level error estimates that
can be used to generate MDCs that are conditional to an individual’s pre- and
post-score (Kozlowski et al., 2016). The conditional minimal detectable change
(cMDC) approach directly addresses all of the key limitations described for the
MDC approach. First, cMDC thresholds are based on measure values from the
Rasch informed interval scaling. This aspect of the cMDC approach addresse
criticisms related to using ordinal data. Second, the cMDC approach accounts for
error associated with the pre- and post-score. This accounts for differences in
error that are present at different points on the scale. Accounting for error
differences could prevent instances where people may have been misclassified
as either having or not having changed. As a result, cMDCs provide the means
for using individual-level data to understand error and identify change. Clinicians
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and researchers alike can use cMDCs and individual-level data for a
personalized approach to evaluating change.

2.3 MEASUREMENT OF WALKING-SPECIFIC MOTOR CONTROL AND
MECHANICS
Walking is a complex activity requiring successful execution of
biomechanical tasks that are controlled by well-coordinated muscle activity
(Gottlieb, 1998). Normal walking is a cyclical movement pattern where one gait
cycle is defined as the period when the reference limb moves from heel strike to
the next heel strike. A normal gait cycle consists of three observable phases: (1)
double limb support, (2) swing phase, and (3) single-leg stance phase. These
phases can be further divided into the following 6 phases or bins of the gait cycle:
(1) initial contact/loading response (initial double support), (2) first half of singleleg stance, (3) second half of single-leg stance (4) second double support, (5)
first half of swing, (6) second half of swing (D. J. Clark, Ting, Zajac, Neptune, &
Kautz, 2010). During each phase of the gait cycle, there are kinematic and kinetic
changes to reflect the accomplishment of key biomechanical tasks; body support,
forward propulsion and leg swing (Zajac, Neptune, & Kautz, 2003). Appropriate
kinematic and kinetic changes and successful biomechanical task completion are
all the result of appropriately activated and timed muscle activity.

Measuring Walking-Specific Motor Control
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There have been several approaches used to measure motor control
during walking. One prominent approach is to quantify the coordination of spatial
and temporal components of measurable gait mechanics (Krasovsky & Levin,
2010; Plotnik, Giladi, & Hausdorff, 2008). However, these approaches do have
some limitations including how to determine an acceptable level of variability
(e.g., cyclograms) (Field-Fote & Tepavac, 2002; Krasovsky & Levin, 2010),
distinguishing between spatial and temporal consistency (e.g., Discrete Relative
Phase Index) (Krasovsky & Levin, 2010), and differentiating symmetry and
variability when accounting for interlimb similarities (e.g., Phase Coordination
Index) (Plotnik et al., 2008).
Another approach to measuring motor control is to use surface EMG.
Surface EMG signals provide a non-invasive means of observing gross
interactions between the nervous system and motor output because EMG is
reflective of the common neural drive a muscle receives. Since walking requires
the contributions of many muscles, it is difficult to quantify comprehensive
measures of the multi-channel EMG and studies examining motor control during
walking were largely qualitative (Knutsson & Richards, 1979). Recently, the use
of statistical factorization methods have provided a way to reduce EMG data from
multiple muscles into a small set of modules, also referred to as modes or
synergies, for quantifying walking-specific motor control (D. J. Clark et al., 2010;
Ivanenko, Cappellini, Dominici, Poppele, & Lacquaniti, 2005; Ivanenko, Poppele,
& Lacquaniti, 2004). Factorization provides a composition of muscle activity
(relative muscle patterns) and temporal representation (pattern activation and
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timing) for each module. Thus, modules are a representation of coordinated
muscle activity during walking that have a link with underlying neural activity
(Bryant A. Seamon, Richard R. Neptune, & Steven A. Kautz, 2018). What is
currently missing from module-based analysis when measuring coordination is
their association with biomechanical task success. Simulation and observational
studies have begun to establish these associations, alleviating some of this
concern (Allen, Kautz, & Neptune, 2013; Bowden, Clark, & Kautz, 2010; D. J.
Clark et al., 2010; Bryant A. Seamon et al., 2018)

Modules
Modules have been used to measure coordination by quantifying the
complexity of coordination (low, medium, high/normal) (D. J. Clark et al., 2010)
and individual muscle pattern weightings and activation curves have been used
to evaluate the quality of coordination when accomplishing biomechanical tasks
of walking (Routson, Clark, Bowden, Kautz, & Neptune, 2013). Initially, there
were concerns that statistical factorization methods (e.x. principal component
analysis, non-negative matrix factorization) may produce findings that are not
physiologically relevant because they are simply mathematical formulas.
However, modules have been relatively consistent across studies that examine
healthy walking (Cappellini, Ivanenko, Poppele, & Lacquaniti, 2006; D. J. Clark et
al., 2010; d’Avella, 2016; Ivanenko et al., 2005; Ivanenko et al., 2004; Tresch,
Cheung, & d'Avella, 2006). Findings from these studies have supported that nonnegative matrix factorization and a common set of eight muscles can produce 4
modules that can account for over 90% of the variation in observed EMG data.
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The composition of muscle activity and activation of each module during the gait
cycle theoretically aligns with biomechanical tasks required for walking and
computer simulations have supported this association (D. J. Clark et al., 2010;
McGowan, Neptune, Clark, & Kautz, 2010; Neptune, Clark, & Kautz, 2009).

The Early Stance module (Module 1) is primarily made up of muscle
activity from knee extensors (rectus femoris and vastus medialis) and gluteus
medius. This module contributes to the biomechanical functions of body support
and backward propulsion (braking). The Late Stance module (Module 2) is
primarily gastrocnemius and soleus activity and contributes to body support and
forward propulsion (acceleration). The Double Burst module (Module 3) contains
two peaks of muscle activity primarily in rectus femoris and tibialis anterior. One
peak contributes to foot clearance during early swing and the second to control of
the foot at heel strike. The Swing to Stance module (Module 4), primarily
composed of medial and lateral hamstring activity, contributes to leg declaration
at the end of swing phase before accelerating the leg in early stance to
accomplish forward progression. Figure 1 below shows the relative muscle
contributions to each module and their relative activation profile over the gait
cycle.
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Figure 1: Modules During Healthy Walking

Figure 1: Muscle compositions (A) and activation-timing profiles (B) for the 4
modules seen in healthy walking at self-selected speeds (n=20). A. Group
averages for muscle weightings are presented with black boxes and standard error
bars. If a muscle was fully represented in a module across all individuals then the
box would be completely gray. B. Individual (thin gray) and group (black) curves
are pictured for each module. The activation timing profiles show the magnitude of
the module’s activation over the gait cycle (averaged to 100 points). Modified from
Clark et. al., 2010 (D. J. Clark et al., 2010).

Muscle Abbreviations: TA, tibialis anterior; SO, soleus; MG, medial
gastrocnemius; VM, vastus medialis; RF, rectus femoris; LH and MH, lateral and
medial hamstring; GM, gluteus medius.
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Modules have also been useful for understanding changes in walkingspecific motor control for persons post-stroke (B. A. Seamon, R. R. Neptune, &
S. A. Kautz, 2018). Persons post-stroke typically walk with fewer modules on the
paretic leg. These modules appear to be merged versions of the healthy modules
described above and correlate with poorer walking performance (Allen et al.,
2013; Barroso et al., 2017; Bowden et al., 2010; D. J. Clark et al., 2010; Coscia
et al., 2015; Gizzi, Nielsen, Felici, Ivanenko, & Farina, 2011; Hashiguchi et al.,
2016; Kautz, Bowden, Clark, & Neptune, 2011; Routson et al., 2013; Routson,
Kautz, & Neptune, 2014). This finding supports the conventional theory of motor
recovery post-stroke that proposes stroke severity is associated with how well an
individual can move out of mass flexion and extension muscle coordination
patterns often seen with merged or fewer modules. As individuals recover, they
progressively gain the ability to move away from these mass activation patterns
and gain more independent control of their movements (D. J. Clark et al., 2010).
Under this framework, more modules equate to more independent control of
muscle coordination patterns (Ferrante et al., 2016; Hashiguchi et al., 2016). This
link between modules and theory is important because clinicians and researchers
have used this theory of motor recovery to hypothesize that an individual’s motor
control level is the cause of altered walking mechanics or biomechanical deficits
commonly seeing in post-stroke walking (Knutsson & Richards, 1979; Ting et al.,
2015). Modules appear to provide a way to quantify coordination that is
representative of the underlying neuropathology caused from a stroke and may
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serve as a biomarker to identify interindividual differences from a mechanistic
viewpoint.

The benefit of a mechanistic biomarker in stroke rehabilitation for walkingspecific motor control recovery
A biomarker for walking-specific motor control recovery would have
several explicit benefits for stroke rehabilitation. Stroke rehabilitation has been
plagued by a reliance on measures that lack a singular mechanistic link with
underlying pathology making it difficult for clinicians and researchers to identify
interindividual differences and impairments for treatment targets (Cramer et al.,
2017). This is particularly true for walking where persons can improve
performance on activity measures (e.x., gait speed) by addressing a variety of
impairments such as strength, balance, and walking-specific motor control
(Bowden, Embry, & Gregory, 2011). A biomarker for walking-specific motor
control recovery could alleviate these problems and provide clinicians with a
framework for providing personalized rehabilitation that targets patient specific
impairments (L. Awad, Reisman, & Binder-Macleod, 2019; L. N. Awad, Lewek,
Kesar, Franz, & Bowden, 2020; Bowden et al., 2012; Bowden, Hannold, Nair,
Fuller, & Behrman, 2008).
The primary challenge for using modules as a biomarker in stroke
rehabilitation is the measure’s limited potential for clinical use. Module analyses
require a sophisticated lab-based gait-analysis, time, and expertise to conduct.
All these factors make it highly unlikely that modules would regularly be
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measured in the clinic. One alternative is to further explore the association
between modules and biomechanics to identify variables that could serve as a
surrogate measure.
Biomechanical variables have been explored as potential biomarkers in
stroke rehabilitation for walking because of their ability to differentiate individuals
post-stroke (L. N. Awad et al., 2020; Louis N. Awad, Reisman, Pohlig, & BinderMacleod, 2016; Balasubramanian, Bowden, Neptune, & Kautz, 2007; Bowden,
Balasubramanian, Neptune, & Kautz, 2006; Mulroy, Gronley, Weiss, Newsam, &
Perry, 2003) and their relative potential for clinical translation given technological
advancements in wearable sensors and movement analysis. Modules provide a
unique way to approach biomechanical variable selection and testing because of
the potential to link biomechanical variables to underlying neural pathology.
Simulation studies support that there is causality between modules and
biomechanical functions in health adults (Neptune et al., 2009). But this still
needs to be explored in in vivo gait studies for both healthy individuals and stroke
survivors to determine the suitability of potential surrogate measures. More
research is needed to understand which biomechanical variables specifically link
with each module observed in healthy persons to inform baseline biomarker
expression. Furthermore, testing is needed to understand how these biomarkers
present in person’s post stroke relative to their individual nervous system
damage and walking ability.
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2.4 PRESCRIPTION AND TREATMENT EFFECTS OF TRANSCRANIAL
DIRECT CURRENT STIMULATION
Transcranial Direct Current Stimulation and Stroke Rehabilitation
Transcranial direct current stimulation (tDCS) is a type of non-invasive
brain stimulation that is a relatively easy to administer, low cost, and safe way to
modulate cortical activity (Schlaug, Renga, & Nair, 2008; Woods et al., 2016).
The potential for modulating the amount of excitability in the cortex has prompted
tDCS to be investigated as a potential adjunct therapeutic in stroke rehabilitation
where interhemispheric imbalances are commonly present (Hummel & Cohen,
2005; Nowak, Grefkes, Ameli, & Fink, 2009). Several studies have already found
positive effects of tDCS on stroke rehabilitation including areas of aphasia
(Fridriksson et al., 2019; Fridriksson et al., 2018), upper (Boggio et al., 2007;
Fregni et al., 2005; Hummel & Cohen, 2005; Kim et al., 2010) and lower
extremity (Nowak et al., 2009; Reis & Fritsch, 2011) function, and walking
(Madhavan & Stinear, 2010; Madhavan, Weber, & Stinear, 2011). However,
these promising findings primarily consist of small effects and bring into question
the realistic therapeutic utility of tDCS, especially with respect to walking
(Lefaucheur et al., 2017; Li, Fan, Yang, He, & Li, 2018; Vaz et al., 2019).

Addressing tDCS Limitations in Stroke Rehabilitation
The high degree of heterogeneity and interindividual differences that is
typical of stroke pathology has become a leading proposed mechanism for the
limited effects of tDCS (Vaz et al., 2019). Understanding what the interindividual
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differences are and their impact on treatment effects of tDCS will be important for
moving this body of work forward. One way to approach this need is by placing a
greater emphasis on study designs that test the effect of varying tDCS
parameters for informing prescription (Fridriksson et al., 2019; Lefaucheur et al.,
2017; Lefebvre & Liew, 2017; Vaz et al., 2019). There are several parameters
that can be investigated. These include parameters related to treatment
frequency, duration, and length, and parameters related to tDCS deliver including
current strength and electrode montage.

The Case for Examining Electrode Montage
A strong case can be made for examining the effects of different electrode
montages with respect to prescription because various pad placements can
induce different modulatory effects. In general, an increase in cortical excitability
can be achieved by placing an anode pad over the target brain region (i.e.,
excitatory stimulus) and a decrease in cortical excitability (i.e., inhibitory stimulus)
can be achieved with a cathode pad placed over the target region. The ability to
target specific brain locations with excitatory or inhibitory stimuli indicates the
potential for addressing interindividual variations within stroke because
prescription of electrode montage can be informed by neuropathology. For
example, pad placement could be targeted to excite the lesioned hemisphere,
inhibit the contralesional hemisphere, or both. Using neuropathology to inform
electrode montage has shown positive effects in studies examining tDCS effects
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on upper extremity and hand function (Boggio et al., 2007; Fregni et al., 2005;
Hummel & Cohen, 2005; Kim et al., 2010).

Current Evidence on Electrode Montage Prescription and Walking
Walking is a unique activity because it is a bilateral, cyclical movement
that engages both cortical hemispheres. Unilateral stroke lesions can be
disruptive to coordination between hemispheres and an underlying impairment
for poor walking performance (Li et al., 2018). Prescribing electrode montage to
correct this imbalance could, in theory, improve walking performance. Studies
examining the effects of tDCS prescribed to treat interhemispheric imbalances
have shown improvements in bilateral upper extremity tasks, but this has not
been explored for walking. It is known that tDCS has shown potential for
augmenting rehabilitation treatment for walking ability in persons post-stroke
(Lefaucheur et al., 2017; Li et al., 2018; Madhavan & Stinear, 2010; Madhavan et
al., 2011; Vaz et al., 2019). Studies specifically examining the effects of electrode
montage have only tested a dual electrode (Ojardias et al., 2019; Tahtis, Kaski, &
Seemungal, 2014; van Asseldonk & Boonstra, 2016). These studies found acute
improvements in walking function (Timed Up and Go (Tahtis et al., 2014) and 6minute walk distance (Ojardias et al., 2019)) and paretic power (van Asseldonk &
Boonstra, 2016). However, to date there are no studies that compare the
differences between an excitatory (anode over target M1 – usually ipsilesional),
inhibitory (cathode over target M1 – usually contralesional), and dual montage
(usually anode over ipsilesional M1 and cathode over contralesional M1). Studies
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are needed that test the immediate effects of each montage compared to sham
stimulation to inform the best prescription for improving walking performance.
Additionally, there are also no studies to date that examine the acute effects of
tDCS with respect to montage on a comprehensive assessment of walking
performance including functional ability, biomechanics, and walking-specific
motor control. Studies evaluating treatment prescription need to take
comprehensive assessments to understand the effects of tDCS on contributors of
walking performance such as biomechanical or neuromotor impairments. This
approach is necessary for understanding interindividual differences that underpin
variations in treatment response which is critical for personalization of
prescription in stroke rehabilitation.
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CHAPTER 3
METHODOLOGY

3.1 INTRODUCTION
This chapter is divided into three parts. Each part presents methodology
specific to one of the three research areas.

3.2 RESEARCH AREA 1: Item Response Theory and Clinical Measurement

Aim 1: Evaluate item-level psychometrics for a patient-reported (the Activitiesspecific Balance Confidence Scale) and clinician-observed (the Functional Gait
Assessment) outcome measure commonly used in stroke rehabilitation.

Aim 2: Demonstrate how item-level psychometrics can be used to inform
personalized treatment planning using an ability map with the Functional Gait
Assessment.

Aim 3: Demonstrate how item-level psychometrics can be used to derive change
scores using individual-level patient data with the Activities-specific Balance
Confidence Scale.
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3.2.1 Study Design
We used a cross-sectional research design to perform tests of
unidimensionality and a Rasch analysis for the Activities-specific Balance
Confidence (ABC) scale and the Functional Gait Assessment (FGA) to answer
Aim 1. Item-level psychometrics generated from the FGA were used to construct
an ability map for informing personalized treatment planning to address Aim 2.
Item-level psychometrics from the ABC scale were used to generate change
scores based on individual-level data to address Aim 3.
All methodology for Part I was considered secondary research. All data
was free of individual identifying information and did not require Institutional
Review Board approval under the revised Federal Policy for the Protection of
Human Subjects (Revised Common Rule)(HHS.gov, 2017)

3.2.2 Dataset Descriptions
Data for analyses with the ABC scale were obtained from the NIH’s
National Institute of Neurologic Disease and Stroke’s Archived Clinical Research
Dataset. The dataset included ABC scale response data for 406 individuals
approximately 2-months post-stroke who were participants in the LocomotorExperience Applied Post-Stroke (LEAPS) trial (P. Duncan, 2012; Pamela W.
Duncan et al., 2011). Individuals who participated in the LEAPS trial were over
the age of 18, could walk at least 10-feet with maximum assistance of one
person, walk slower than 0.8 m/s, and were living in the community at the time of
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enrollment (P. W. Duncan et al., 2007). The LEAPS trial was a phase 3, multisite,
randomized control trial and the full inclusion and exclusion criteria can be found
in Duncan et. al., 2007 (P. W. Duncan et al., 2007). All response data for the
ABC scale were from the LEAPS baseline assessment and there were no
missing data points.
Data for the analyses with the FGA were provided by a shared database
maintained by the NIH Center for Biomedical Research Excellence (COBRE) in
Stroke Recovery at the Medical University of South Carolina. The database
includes data for research participants who participated in studies held at the
COBRE in Stroke Recovery and consented to having their information archived
for future research studies. The shared database is approved by the Institutional
Review Board at the Medical University of South Carolina. The database
provided a dataset with FGA response data for 101 individuals post-stroke. The
date for FGA data collection was used to link demographic variables and
calculate participant’s ages and time since stroke. The FGA data collection date
was also used to link to lower-extremity Fugl-Meyer scores and overground selfselected walking speed. Trained physical therapy staff conducted and scored the
FGA for all individuals. Individuals completed the FGA without an assistive
device or orthotics. However, an aircast was allowed when individuals had
severe paretic ankle instability to prevent injury.

3.2.3 Rasch Analysis and Tests of Unidimensionality
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Rasch analysis for both scales was completed in Winsteps [version
3.93.1; John Lincare/Winsteps.com, Beaverton, OR, USA]. Tests for
unidimensionality and local dependence were completed with Mplus [version 7.4;
Muthén & Muthén, Los Angeles, CA, USA] for the ABC scale and in R [version
3.6.1; R Foundation for Statistical Computing; Vienna, Austria] (Team, 2019) with
the following packages: ‘lavaan’ (Rosseel, 2012), ‘psyc’ (Revelle, 2020), and
‘polycor’ (Fox, 2019) for the FGA.

Rating-Scale Structure
Rating-scale structure was evaluated with Linacre’s 3 category ratingscale criteria: (1) a minimum of 10 observations per rating-scale category, (2)
rating-scale category average measures advance monotonically (i.e.,
demonstrate increasing item difficulty with increasing category value) and (3)
outfit mean-squares are less than 2 (J.M. Linacre, 2003).
Category probability curves were visually inspected to confirm distinct
peaks for each category of the rating-scale. Distinct peaks for category
probability curves indicate each rating-scale category is the most probable
response for a specific portion of the measurement scale (Bond & Fox, 2015).
If the rating-scale structure did not meet the designated criteria or
demonstrate distinct peaks for category probability curves, then we applied
modifications to the rating-scale to best fit the established criteria for the Rasch
model.
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Unidimensionality
We tested the ABC scale and FGA for unidimensionality after making
modifications to the rating-scale structure if they were required. A one-factor
confirmatory factor analysis was used to evaluate unidimensionality.
Recommendations from Reeve et. al., 2007 were used to evaluate the model fit:
(1) comparative fit index >0.95, (2) root mean square error approximation <0.06,
(3) Tucker-Lewis Index >0.95, and (4) standardized root mean residuals <0.08
(Reeve et al., 2007). If the one-factor model did not meet the recommendations,
we performed an exploratory factor analysis to test for additional factors. We
compared model fit from the exploratory factor analysis to the same
recommendations used in the confirmatory factor analysis. In addition, we
weighed accepting additional factors using: (1) the eigenvalue ratio between the
first and second factors (greater than 4 indicates sufficient unidimensionality), (2)
scree plot visualization, and clinical interpretation.

Local Dependence
The Rasch model assumes that items have local independence. Local
independence of items means that there are no significant associations among
item responses when controlling for the measure’s dominant factor.(Reeve et al.,
2007) We evaluated for local independence of items using a residual correlation
matrix from the one-factor confirmatory factor analysis. If residual correlations
were >0.2 or <-0.2 between two items we considered them to be locally
dependent. (Reeve et al., 2007)
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Item and Person Fit
The fit of items and persons to the Rasch model were evaluated with fit
statistics. Items or individuals were considered misfitting when outfit statistics had
mean-square standardized residuals greater than or equal to 1.4 and standardized
z-scores greater than or equal to 2 (J.M. Linacre, 2003; Wright & Linacre, 1994).

Item Difficulty Hierarchy
We evaluated the FGA’s theoretical construct validity with the item
difficulty hierarchy generated by the Rasch model. We also used the item
difficulty hierarchy to evaluate the extent that items overlapped. Items were
considered to overlap if the measure estimates for any two items were within 2
standard errors.

Person-Item Match
We evaluated for floor and ceiling effects. We considered the scale to
have a floor and/or ceiling effect if more than 15% of individuals scored the worst
or best possible measure value (Lim et al., 2015).

Separation Index
The person separation index was used to quantify how well each scale
differentiated people into statistically distinct strata. The following formula was
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used to calculate the number of strata from the person separation index (Wright
& Masters, 2002):
Strata = [4*(person separation index)+1]/3

3.2.4 Ability Map Development
We developed an ability map for the FGA from a keyform that is generated
by Winsteps during the Rasch analysis to address Aim 2. A keyform is a tool that
can be used to score persons on individual items and then quickly generate the
person’s measure value. The keyform presents the items in difficulty hierarchy on
the right vertical axis and the measure values on the horizontal axis. The items
are clustered with items of similar difficulty and clusters are separated by a
horizontal blank space. Each row for the items contains the available rating-scale
categories. The rating-scale categories for each FGA item correspond to the
original score system: 0=severe impairment, 1=moderate impairment, 2=mild
impairment, and 3 = normal.
A rater can use a keyform by circling the score for each item and then
drawing a vertical line through the “bulk” of the circles to x-axis. The line
intersects with the x-axis to provide an approximation of the person’s measure
value on the Rasch model. Measure values are typically generated on the logit
scale. The logit scale anchors the mean to 0 and standard deviation to 1. Logit
scales can be transformed by selecting a new anchor for the mean and rescaling
the measures. We chose to convert the logit scale to a scale from 0-30 to mimic
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the traditional FGA scale and enhance the clinical interpretability of measure
values.
We presented three patient scenarios to demonstrate how a keyform can
be used as an ability map to generate personalized treatment planning from
individual patient responses to items on the FGA. We separated our sample into
tertials based on their measure values to represent high, moderate, and low
ability levels. We randomly selected an individual from each tertial and evaluated
their fit statistics to ensure they did not misfit the Rasch model. Each individual’s
response data was used to complete a keyform score sheet and generate an
estimate of their measure value. We discuss how the keyform can be interpreted
as an ability map by clinicians for personalized treatment planning.

3.2.5 Change Threshold Determinations
We calculated conditional change thresholds, also known as conditional
minimal detectable change (cMDC), using item-level psychometrics generated
from our Rasch analysis of the ABC scale to address Aim 3. We also calculated
a traditional change threshold, also known as minimal detectable change (MDC),
using group-level data for the ABC scale from our dataset. We used theoretical
patient examples to demonstrate the differences between cMDCs and an MDC
for classifying patients as having a detectable change.

Calculating cMDC Thresholds
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Rasch analysis generates an interval scale with measure values in logits.
Each logit has an associated standard of error (SE). We converted the logit scale
back to a 100-point scale (0-100) by anchoring the mean and scaling measure
values with the same approach described for the FGA analysis. We applied this
transformation to help improve the clinical interpretability of measure values on
the interval scale. The transformation also helps improve the interpretability of
comparisons between the cMDC and MDC, which relies on the traditional ABC
scale scoring system.
We used the SE generated with each measure value to calculate a cMDC
threshold with a 95% confidence interval (cMDC95) for every possible pair of preand post-score combinations using the following formula (Kozlowski et al., 2016):

cMDC95 = ([SEpre-score-SEpost-score]/2)*1.96*√(2)

Calculating MDC Thresholds
We calculated the standard error of measurement (SEM) which represents
group-level error data for the ABC scale with original scores (i.e., prior to Rasch
analysis) in the following formula (Wyrwich, 2004):

Standard Error of Measurement (SEM) = Standard Deviation *√(1-Cronbach Alpha)

Next, we calculated one MDC threshold with a 95% confidence interval
(MDC95) with the following formula (P. W. Stratford, Binkley, Riddle, & Guyatt,
1998):
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MDC95 = 1.96*√(2)*(SEM)

Comparing cMDC and MDC Thresholds
We plotted all possible cMDC95 thresholds associated with each person
measure on the cMDC scale to visualize the effect of individual-level standard
error on the threshold for detecting change across the ABC scale. We also
plotted the MDC95 as a horizontal line across the scale to illustrate differences in
the approach for detecting change. Finally, we extracted three of the cMDC95
curves to show three theoretical patient scenarios to examine if there are
differences in how change is detected between approaches. We selected a low
(25), moderate (50), and high (75) initial score for the patient scenarios to
capture the differences between a cMDC95 and MDC95 approach across three
representative ability levels.

3.3 RESEARCH AREA 2: Searching for Biomarkers to Inform Patient
Subgroups

Aim 1: Quantify the association between walking-specific motor control and
quantifiable biomechanical variables during steady-state self-selected walking for
healthy individuals.
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3.3.1 Study Design
We used a cross-sectional research design with health, communitydwelling individuals. Participants completed a laboratory gait analysis consisting
of walking on an instrumented treadmill for three, 30-second bouts of selfselected treadmill walking. Study procedures were approved by the Institutional
Review Board at the Medical University of South Carolina and conformed to the
Declaration of Helsinki. All participants signed a written informed consent form
prior to enrollment.

3.3.2 Participants
We enrolled 20 healthy adults between 40 to 85 years of age. Participants
were excluded if they had any neurologic diseases or significant orthopedic
impairments in their legs (e.g., pain, amputation, severe osteoarthritis, etc.) that
would limit walking ability or alter motor control.

3.3.3 Experimental Procedures
All participants walked for three, 30-second bouts of self-selected walking
on an instrumented treadmill (Bertec; Columbus, OH). Kinetic, kinematic, and
electromyographic (EMG) data were collected during each trial. We sampled
ground reaction forces at 2000 Hz to derive kinetic variables. Ground reaction

37
force data was filtered with a 4th order Savitzky-Golay filter and resampled at
100 Hz. We collected whole-body 3D kinematic measures using a 16-camera
motion capture system (PhaseSpace, Inc.; San Leandro, CA). Motion capture
data was sampled at 120 Hz, filtered with a 4th order Savitzky-Golay filter, and
resampled at 100 Hz. EMG data were collected from surface bipolar preamplified electrodes (Motion Lab Systems; Baton Rouge, LN, USA) and sampled
at 2000 Hz. We collected EMG data from eight muscles bilaterally: tibialis
anterior, soleus, medial gastrocnemius, vastus medialis, rectus femoris, medial
hamstrings, lateral hamstrings, and gluteus medius. EMG data was high-pass
filtered at 40 Hz, demeaned, rectified, low-pass filtered at 4 Hz using a zero-lag
forth order Butterworth filter, and resampled to 100 Hz. EMG amplitude for each
muscle was averaged within each region of the gait cycle (or bin): (1) initial
contact/loading response (initial double support), (2) first half of single-leg stance,
(3) second half of single-leg stance (4) second double support, (5) first half of
swing, (6) second half of swing) for each step. The bin with the highest average
was used to normalize EMG amplitude across all trials for an individual. Lastly,
data for each step was time normalized to the gait cycle (0-100%).

Data Analysis
BIOMECHANICAL VARIABLES: We derived biomechanical variables from
kinetic and kinematic data using custom MATLAB software (Mathworks, Natick,
MA) to represent the biomechanical subtasks of walking. Each biomechanical

38
variable was calculated per bin per step for each leg. Variables of interest
included:

(1) Changes in ground reaction force or impulse (the time integral of the ground
reaction force) in the anterior-posterior (AP) and vertical directions. We
calculated net impulse (area under the curve; AUC) from the ground reaction
force components.

(2) Changes in anterior-posterior leg angle (sagittal plane of motion). Leg angle
was calculated by taking the angle between a vertical line from the center of
mass of the pelvis to the ground and a line from the center of mass of the pelvis
to the center of mass of the foot. The change in anterior-posterior leg angle was
represented by the net AUC of the leg angle measurement over each bin of the
gait cycle.

(3) Changes in leg length. Leg length was calculated as the distance from the
center of mass of the pelvis to the center of mass of the foot. Leg length was
normalized for each participant to the distance between their pelvis center of
mass and foot center of mass during static standing. The change in leg length
was represented by the positive AUC of the leg length over each bin of the gait
cycle.
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EMG VARIABLES: We quantified muscle coordination using a module analysis
of EMG data with Non-negative Matrix Factorization (NNMF). EMG from each
muscle for per leg was combined into an m x t matrix (EMGO), where m is the
number of muscles (8) and t is the time base (t = number of gait cycles x 101).
We then applied an NNMF algorithm to the m x t matrix for each participant.
NNMF creates two matrices that define a pre-selected number of modules (n).
We pre-selected the number of modules to be 4 based on previous research in
healthy individuals from our lab (D. J. Clark et al., 2010). One matrix from NNMF
is an m x n matrix with the relative weighting of each muscle within each module
(W matrix). The second is an n x t matrix indicating the activation timing profile of
each module for each step in the trial (H matrix). A key assumption of NNMF is
that muscle weightings are fixed across all steps and muscles can belong to
more than one module. NNMF runs an iterative optimization procedure to
minimize the error between EMGO and a reconstructed EMG signal (EMGR)
created by the m x n and n x t matrices. We quantified module activation by
taking the AUC under each module’s H matrix curve within each bin of the gait
cycle per step.

Statistical Analysis
We fit linear mixed models with random coefficients (PROC GLIMMIX) to
quantify the association between module and biomechanical variables at the
group-level while controlling for variability at the individual-level. We identified the
participant variable, participant by leg (i.e., right and left) interaction, and
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participant by step interaction as random effects. We examined the following
comparisons: Module 1 with anterior-posterior and vertical ground reaction forces
in bins 1 and 2; Module 2 with anterior-posterior and vertical ground reaction
forces, and trailing leg angle during bins 3 and 4; Module 3 with anterior-posterior
ground reaction forces during bin 4, and leg angle and leg length during bins 5
and 6; and Module 4 with anterior-posterior and vertical ground reaction forces
during bin 1, and leg angle in bin 6. We quantified the magnitude of association
with parameter estimates and we used a Bonferroni correction for the number of
tests (tests = 18) for an alpha level of 0.003. All analyses were done in SAS
version 9.4 (SAS Inc., Cary, NC).

3.4 RESEARCH AREA 3: Evaluating Treatment Prescription

Aim 1: Determine whether electrode montage type acutely influences walking
performance.

3.4.1 Study Design
We used a double-blind, randomized, cross-over experimental design.
Participants completed a clinical battery of assessments including the lowerextremity Fugl-Meyer, Berg Balance Test, and Dynamic Gait Index at enrollment.
Participants then completed three single session tDCS experimental conditions
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where electrode montage was varied and one session of sham simulation. We
block randomized sessions to control for order effects and separated sessions by
a minimum 48-hour period for washout. Primary gait outcome measures were
collected pre- and post-stimulation at each experimental session. EMG outcome
measures were collected pre-stimulation on the participants first session and
post-stimulation for all experimental sessions.
All study procedures were conducted by a team of licensed physical
therapists and associated study staff. This study was approved by the
Institutional Review Board at the Medical University of South Carolina and
conformed to the Declaration of Helsinki. All participants signed written informed
consent.

3.4.2 Participants
We enrolled 18 individuals with chronic stroke. One individual dropped out
and one did not meet inclusion criteria. The remaining 16 individuals completed
all study procedures and were included in the analysis. Inclusion criteria for the
study were: 1) age 18 to 85 years old; 2) at least six-months post-stroke; 3)
residual lower extremity paresis (Fugl-Meyer Lower Extremity motor score <34);
4) ability to walk independently at least 10 feet; 5) self-selected 10-meter gait
speed < 0.8 m/s (at time of consent); and 6) provision of informed consent.
Individuals were excluded if they met any of the following criteria: 1) significant
musculoskeletal problems limiting hip and knee extension or ankle plantarflexion
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to neutral joint positions; 2) self-reported history of unstable cardiovascular
disease or severe osteoporosis, or 3) pregnancy.

3.4.3 Experimental Procedures
Participants received tDCS from an EMPI unit (Chattanooga; Hixson, TN).
Sponges were cut to a 1.75 cm2 size and prepped with a 0.9% saline solution to
deliver a current density of 0.1 mA/cm2 (Thair, Holloway, Newport, & Smith,
2017). Stimulation was ramped up to 2 mA and continued for 20 minutes to
generate a dose rate of 40 mA/min. Participants were informed that they would
feel a slight tingling sensation at the onset of stimulation that would resolve in
approximately 60 seconds. Participants completed 3 single session tDCS
experimental conditions where electrode montage was manipulated: 1)
excitatory, 2) inhibitory, and 3) dual and one session of sham stimulation. In the
excitatory condition the anode pad was placed over the target ipsilesional leg M1
area with the reference pad on the ipsilateral shoulder. In the inhibitory condition
the cathode pad was placed over the target contralesional leg M1 area with the
reference pad on the ipsilateral shoulder. In the dual condition we used two EMPI
units to deliver simultaneous anodal stimulation over the ipsilesional M1 and
cathodal stimulation over the contralesional M1. The reference pads for each
EMPI unit were placed on the respective ipsilateral shoulder. The dual condition
allowed for the excitatory and inhibitory montages to be applied simultaneously to
target both leg M1 areas. This type of pad placement (active pads with a cortical
placement, and reference pads on the ipsilateral shoulder) has been shown to
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have a deeper current penetration depth in modeling studies (Noetscher,
Yanamadala, Makarov, & Pascual-Leone, 2014). This pad placement also was
shown to have a greater effect on excitability (Tatemoto, Yamaguchi, Otaka,
Kondo, & Tanaka, 2013) and neuromotor output (Angius, Pageaux, Hopker,
Marcora, & Mauger, 2016) in lower extremity areas of M1 compared to other
types of pad placement. In addition to the experimental conditions, participants
completed one session with sham stimulation. Sham stimulation was achieved by
turning on the EMPI unit to apply 30 seconds of stimulation before an unblinded
investigator turned the units off (Tanaka et al., 2011). During the sham
stimulation, participants would feel the initial tingling sensation that would resolve
in about 60 seconds like the experimental conditions and be unable to distinguish
if the unit had been turned off or not. Blinding for participants and staff was
maintained by using the same set up as described in the dual condition across all
sessions. We estimated the location of M1 in each hemisphere by placing the
pad 1cm lateral to the vertex and 1cm posterior to a hypothetical line between
the tragi of each ear while the participant was in a forward seated position. This
created a 2 cm gap between cephalic pad placements.
Each session (3 experimental conditions and sham) began with
participants receiving the first 5 minutes of stimulation seated before walking the
remaining 15 minutes on a treadmill while stimulation continued. Participants
walked at their fastest-comfortable speed on the treadmill to mimic an adequate
training stimulus used for rehabilitation (Lamontagne & Fung, 2004; Sullivan,
Knowlton, & Dobkin, 2002). Several measures were taken to maintain patient
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safety during testing. Participants were attached to a ceiling harness system to
prevent falls and walking was paused every 5 minutes to assess vital signs.
Walking was immediately discontinued if required for participant safety. Minimal
physical assistance or verbal cues were provided to help participants avoid
tripping during the 15-minute walking period with stimulation. No physical
assistance or verbal cues were provided during pre- and post-stimulation data
collections.

Data Analysis
Data collection for outcome measures were completed pre- and
immediately post-stimulation for each experimental session. Participants walked
over a 24-foot GaitRite (CIR Systems, Inc.; Franklin, NJ) for one trial at their selfselected walking speed and three trials at their fastest-comfortable walking speed
during pre- and post-testing to determine overground walking speeds. Next,
participants walked for three, 30-second trials at self-selected and again at
fastest-comfortable walking speeds on a split belt instrumented treadmill (Bertec;
Columbus, OH). Treadmill speeds were selected by participants independent
from overground speeds and the two conditions did not have to match. Paretic
step ratio and paretic propulsion were calculated from ground reaction force data
sampled at 1000 Hz during treadmill walking using methods previously described
by our lab (Bowden et al., 2006). We calculated paretic propulsion by dividing the
positive anterior impulse of the paretic leg by the anterior impulse of both legs
combined (Bowden et al., 2006). We calculated paretic step ratio from the
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percentage of stride length performed by the paretic step (Balasubramanian et
al., 2007). We expressed paretic step ratio and paretic propulsion as the absolute
value of deviation from symmetry.
We collected EMG data during self-selected treadmill walking to examine
muscle coordination changes in response to tDCS stimulation. We quantified
muscle coordination by extracting modules from EMG data using a non-negative
matrix factorization (NNMF) algorithm (Lee & Seung, 1999; Ting & Macpherson,
2005). We recorded surface EMG at 2000 Hz with bipolar pre-amplified
electrodes (Motion Lab Systems; Baton Rouge, LN, USA) from eight leg muscles
bilaterally: tibialis anterior, soleus, medial gastrocnemius, vastus medialis, rectus
femoris, medial hamstrings, lateral hamstrings and gluteus medius (Hermens,
Freriks, Disselhorst-Klug, & Rau, 2000). EMG signals were pre-processed before
using the NNMF algorithm to select the number of modules for the paretic leg.
EMG signal processing and module selection criteria can be found in Clark et.
al., 2010 (D.J. Clark, Subramanian, Neptune, & SA, 2008). Pre-stimulation
number of modules was determined for each individual at their initial session.
Post-stimulation number of modules was determined immediately following tDCS
or sham stimulation during self-selected treadmill walking trials.

Statistical Analysis
All statistical analyses were conducted using SAS version 9.4 (SAS
Institute Inc. Cary, NC). We ran all analyses using change scores for gait speed,
paretic step ratio and paretic propulsion at self-selected and fastest comfortable
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speeds. We used a one-way ANOVA (or Kruskal-Wallis Test for non-parametric
data) to examine the main effect of active stimulation across all three montages
compared to sham for each variable of walking performance. Post-hoc testing
with multiple t-tests (or Wilcoxon Rank-Sum tests) were performed to compare
the effects of each electrode montage when indicated. We conducted a
secondary, exploratory analysis to examine the effect of tDCS to sham
accounting for an individual’s best response to the three electrode montages. We
identified everyone’s best response for each variable with respect to electrode
montage. We pooled these values to generate a group average response to
stimulation and compared it to sham stimulation using t-tests (or Wilcoxon RankSum tests). We accepted a higher alpha-value of 0.1 for this analysis to inform
hypothesis generation. Changes in module number are reported observationally
to generate hypotheses for future studies. We performed Spearman’s correlation
between changes in module number and other self-selected walking outcome
variables to explore associations between muscle coordination and walking
performance.
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CHAPTER 4
MANUSCRIPTS

4.1 INTRODUCTION
Chapter 4 is divided into three parts. Each part addresses one of the
research questions and contains manuscripts that were written to present the
findings.

PART 1
Part 1 contains the following manuscripts:
1. Rasch Analysis of the Activities-Specific Balance Confidence Scale in
Individuals Post-Stroke
2. Item-level Psychometrics for the Functional Gait Assessment in
Persons with Stroke
3. Revisiting the concept of minimal detectable change for patientreported outcome measures

PART 2
Part 2 contains the following manuscript:
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1. Associations between biomechanical variables of walking performance
and muscle coordination during self-selected steady-state walking

PART 3
Part 3 contains the following manuscript:
1. tDCS electrode montages may differentially impact variables of walking
performance in individuals post-stroke: a preliminary study
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4.2 PART I MANUSCRIPTS

Rasch Analysis of the Activities-Specific Balance Confidence Scale in Individuals
Post-Stroke

Functional Gait Assessment Item-level Psychometrics for Measurement of
Walking Balance Ability in Persons with Chronic Stroke

Revisiting the concept of minimal detectable change for patient-reported outcome
measures
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Abstract
Objective: To examine the psychometric properties of the Activities-specific
Balance Confidence (ABC) scale using Rasch analysis for individuals poststroke.

Design: Retrospective cohort.

Setting: Data was extracted from the Locomotor Experience Applied Post-Stroke
(LEAPS) phase three, multisite, randomized controlled clinical trial.

Participants: 406 community-dwelling, ambulatory, older-adults (mean age
61.97 years SD12.76; 45.07% female) approximately 2-months post-stroke.

Intervention: None.

Main Outcome Measures: We examined unidimensionality, local dependence,
rating-scale structure, item and person fit, person-item match, and separation
index of the ABC scale.

Results: Confirmatory and exploratory factor analysis showed the ABC scale
was adequately unidimensional and three item pairs had local dependence. A
collapsed 5-category rating-scale was superior to the 101-category scale. The
hardest item was “walking outside on an icy sidewalk”, the easiest item was
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“getting into or out of a car”, and no items misfit. The ABC scale had high person
reliability (0.93), despite 10.5% of individuals misfitting the expected response
pattern. Mean ability level of the sample was slightly lower (-0.56 logits) than the
mean item difficulty indicating that the ABC scale adequately matched our
sample’s balance confidence. The ABC scale did not have a floor or ceiling effect
and separated individuals into 5 statistically distinct strata (separation
index=3.71).

Conclusions: The Rasch model supports the use of the ABC scale to measure
balance confidence in individuals’ post-stroke. The consistency of our results with
previous Rasch analyses on the ABC scale demonstrates the instrument
responds similarly across multiple populations; community-dwelling older-adults,
outpatient orthopaedic physical therapy, stroke, Parkinson’s disease, and lowerlimb amputation. Recommendations include collapsing the rating scale and
developing a computerized-adaptive test version of the scale to enhance clinical
utility.

Key Words: Stroke, Psychometrics, Outcome Assessment, Postural Balance

Abbreviations: ABC scale; Activities-specific Balance Confidence scale, ANPT;
Academy of Neurologic Physical Therapy, CFA; confirmatory factor analysis,
EFA; exploratory factor analysis
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INTRODUCTION
Individuals post-stroke are at high risk for devastating consequences from
falls including increased health care utilization and fracture rate1, 2 with
approximately 3 of 4 individuals falling during the first 6 months back at home
and up to one quarter experiencing recurrent falls.3, 4 Since falls are associated
with fear of falling and balance confidence5, measurement of an individual’s
confidence in their balance is an important component of clinical practice for
physical therapists in stroke rehabilitation. The Activities-specific Balance
Confidence (ABC) scale was designed to measure balance confidence and takes
approximately 20 minutes to complete.6 Individuals rate their confidence that they
“will not lose their balance or become unsteady” when performing each daily task
(item) on the scale from 0% (low confidence) to 100% (high confidence). A total
score is calculated by averaging scores from all 16 items.
The ABC scale is widely used in stroke rehabilitation7 and has
psychometric evidence to support its use for quantifying balance confidence in
stroke survivors.8-13 Total scores on the ABC scale have concurrent validity with
measures used to assess activity and participation domains of the International
Classification of Functioning, Disability and Health including the Berg Balance
Scale9-11, walking speed9, 10, 12, 13, Timed-up and Go10, 12, 13, six-minute walk test10,
12,

Barthel Index10, Lower Extremity Fugl-Meyer Assessment11, five-time sit-to-

stand test11, modified Rivermead Mobility Index13 and physical function scale of
the SF-3610, 12. The ABC scale also has strong internal consistency13, strong testretest reliability for the scale’s total score (intraclass correlation coefficient
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[ICC]=0.859, 0.8212) and moderate to strong test-retest reliability at the item level
(ICC range 0.53-0.93)9. The majority of individuals post-stroke score between 2080% suggesting there is not a floor or ceiling effect and standard error of
measurement has been reported between 6.819 and 5.0510. Cut-off values for
distinguishing between individuals with a history of multiple falls and no falls after
suffering a stroke has been reported as 81.18 and 63.7514, where lower
confidence is associated with more falls.
However, no studies have examined measurement characteristics of the
ABC scale for stoke survivors using item response theory psychometric methods,
like Rasch analysis. Rasch analysis takes advantage of probabilistic
mathematical modeling to examine a measurement tool’s ability to quantify
abstract constructs in a meaningful way. This is accomplished by assuming the
probability of successfully passing an item is dependent on the relationship
between a person’s ability and item difficulty. Results from a Rasch model orders
a measure so scores can be interpreted linearly with set interval distances.15
Often, Rasch analysis identifies items that overlap in measurement properties
and can be used to develop short forms or computerized-adaptive tests to reduce
the time required to administer an instrument.16
Previous studies examined the ABC scale with Rasch analysis in different
populations; Arnadottir et. al. (community-dwelling older adults)17, Sakakibara et.
al. (lower-limb amputees)18, Franchignoni et. al. (Parkinson’s disease)19, and
Wang et. al. (outpatient physical therapy)20. These studies found similar
psychometrics for the ABC scale indicating that Rasch methods may support the
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comparison and use of the scale across patient populations, which is
recommended for physical therapists in neurologic physical therapy practice by
the Academy of Neurologic Physical Therapy (ANPT).21
Therefore, the purpose of this study is to examine the ABC scale using
Rasch analysis for individuals post-stroke. We hypothesize the ABC scale will fit
the Rasch model for these individuals similarly to other populations. Results from
this analysis will provide support for comparison and use of the ABC scale across
populations as recommended by the ANPT.

METHODS
Data Source
This study is a secondary analysis of data from 406 individuals post-stroke
who participated in the Locomotor Experience Applied Post-Stroke (LEAPS)
phase three, multisite, randomized controlled clinical trial.22 Institutional Review
Board approval of this secondary analysis was not required because data was
free of identifiers. Included individuals had a stroke and (1) were greater than 18
years old, (2) were able to ambulate a minimum of 10 feet with maximum 1person assist, (3) had a self-selected walking speed less than 0.8 m/s, and (4)
were living in the community.23 Individuals were excluded who had (1) additional
neurologic pathology and co-morbidities, (2) severe pain, amputation or
orthopaedic conditions limiting ambulation, or (3) severe cardiovascular
comorbidities that would prevent participation in high intensity exercise.23
Demographic data for the trial was collected during an enrollment window (within
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30 days of diagnosis).23 We analyzed ABC scale data collected at approximately
2 months post-stroke (Baseline Assessment). Summary demographic data was
analyzed with SAS version 9.4a and presented in Table 1.

(Insert Table 1)

Rasch Analysis
Rasch analysis of the ABC scale was done with Winsteps version 3.93.1b.
Tests of unidimensionality and local dependence were performed in Mplus
version 7.4c.

Rating-Scale Structure
Appropriateness of the rating scale structure was determined based on
Linacre’s 3 rating-scale criteria24; (1) each rating-scale category has a minimum
of 10 observations, (2) average measures within each category advance
monotonically (i.e., demonstrate increasing observed item difficulty with
increasing category value) and (3) outfit mean-squares are less than 2. Category
probability curves were examined to see if categories of the rating-scale had
distinct peaks (indicating each category of the rating-scale is the most probable
response for a given portion of the measure).15 The rating-scale was collapsed
for further analysis if it did not meet designated criteria.

Unidimensionality
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An assumption of the Rasch model is that the measure is unidimensional.
A confirmatory factor analysis (CFA) with one factor was performed on a random
sample from our data (n=203) to assess unidimensionality. Model fit from the
CFA was evaluated against recommendations from Reeve et. al., 2007:25 (1)
comparative fit index >0.95, (2) root mean square error approximation <0.06, (3)
Tucker-Lewis Index >0.95, and (4) standardized root mean residuals <0.08. If
model fit was poor, an exploratory factor analysis (EFA) was done on another
random sample (n=203) to determine additional factors. Additional factors from
EFA were evaluated on model fit (Reeve’s recommendations25), eigenvalue ratio
(greater than 4 indicates sufficient unidimensionality), visualization of the scree
plot, and clinical interpretation.

Local Dependence
Local independence assumes no significant associations among items
responses when controlling for the dominant factor of the measure.25 A residual
correlation matrix from the CFA was used to identify dependent item pairs.
Residual item correlations >0.2 or <-0.2 were considered locally dependent.25

Item and Person Fit
Items or individuals were classified as misfitting if fit statistics had meansquare standardized residuals greater than or equal to 1.4 and standardized zscores greater than or equal to 2.24, 26
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Item Difficulty Hierarchy
Item difficulty was used to evaluate theoretical construct validity of the
ABC scale. The Rasch model assigns item difficulty and person ability measures
to a logit scale. Items that are easier or persons with lower ability are assigned
lower values and items with higher difficulty or persons with high ability are
assigned higher values. Item measure estimates were used to determine if items
overlapped. Items were considered overlapping if the item’s measure estimate
was within 2 standard errors of another item.

Person-Item Match
Observation of the person-item map was used to evaluate for floor (within
error of worst possible outcome [raw score 0/100]) and ceiling effects (within
error of best possible outcome [raw score 100/100]). We considered the ABC
scale to have a floor or ceiling effect if greater than 15% of individuals scored the
worst or best possible outcomes.27

Separation Index
The person separation index was used to evaluate the ABC scale’s ability
to differentiate people into statistically distinct strata. The number of strata were
determined from the following formula28:
Strata = [4*(person separation index)+1]/3

RESULTS
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Rating-Scale Structure
We initially analyzed the data using a 101-category (0-100%) rating-scale.
Only a few rating-scale categories had more than 10 observations. No outfit
mean-squares values exceeded 2.0, however, there were disordered rating-scale
estimates. Collectively, this demonstrates that rating-scale categories were
under-used, and the ABC scale was not adequately fitting the Rasch model.
Therefore, we tested a collapsed 5-category rating-scale based on previous
publications (0-9%, 10-30%, 31-60%, 61-90%, 91-100%).18, 20 The new ratingscale had more than 10 observations per category, demonstrated appropriate
rating-scale estimates of increasing ability level (rating-scale categories
advanced monotonically), and no category exceeded the outfit mean square
threshold of 2. The rating-scale structure results are presented in Table 2.

(Insert Table 2)

Unidimensionality
CFA using the collapsed rating-scale returned the following fit statistics;
(1) comparative fit index 0.95 (>0.95 indicates good fit), (2) root mean square
error approximation 0.15 (<0.06 indicates good fit), (3) Tucker-Lewis Index 0.95
(>0.95 indicates good fit), and (4) standardized root mean residuals 0.09 (<0.08
indicates good fit).
EFA returned two factors with eigenvalues >1.0 and the following fit
statistics for a two factor model; (1) comparative fit index 0.96 (>0.95 indicates
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good fit), (2) root mean square error approximation 0.14 (<0.06 indicates good
fit), (3) Tucker-Lewis Index 0.95 (>0.95 indicates good fit), and (4) standardized
root mean residuals 0.05 (<0.08 indicates good fit). Eigenvalues for the first two
factors were 10.17 and 1.41, respectfully. The second factor included the
following items; “stand on your tiptoes and reach for something above your
head”, “stand on a chair and reach for something”, “sweep the floor”, “walk in a
crowded mall where people rapidly walk past you”, “are bumped into by people
as you walk through the mall”, “step onto or off an escalator while you are holding
onto a railing”, “step onto or off an escalator while holding onto parcels such that
you cannot hold onto the railing”, “walk outside on icy sidewalks”. The ratio of
eigenvalues for the first and second factor is 7.21 and visual interpretation of the
scree plot favors accepting only one factor. Although all criteria were not met, the
results of the factor analysis support that the ABC scale adequately meets the
assumption of unidimensionality.

Local Dependence
Three item pairs were found to have local dependence; (1) “walk outside
on icy sidewalks”–“walk outside the house to a car parked in the driveway” (r=0.23), (2) “walk outside the house to a car parked in the driveway”–“step onto or
off an escalator while holding onto parcels such that you cannot hold onto the
railing” (r=-0.25), and (3) “walk outside on icy sidewalks”–“reach for a small can
off a shelf at eye level” (r=-0.21).
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Item and Person Fit
No items misfit the Rasch model. The findings related to item fit are
reported in Table 3. Forty-three individuals (10.6%) responses did not fit with the
Rasch model (mean-square standardized residuals greater than or equal to 1.4
and standardized z-scores greater than or equal to 2 of fit statistics.24, 26). We
found nearly identical results from the Rasch analysis when misfitting persons
were removed. Therefore, we are reporting findings for the whole sample
because (1) individuals included in the sample are largely representative of
community-dwelling stroke survivors and (2) the ABC scale is designed and
advocated to be broadly applicable for this patient population. The ABC had high
person reliability (0.93) and Cronbach’s alpha (0.95).

Item Difficulty and Person-Item Match
The results of the item difficulty analysis are presented in Table 3 and
visually displayed using a Person-Item map in Figure 1. The hardest item was
“walking outside on icy sidewalks” while the easiest item was “getting into or out
of a car”.

(Insert Table 3)

The Person-Item map in Figure 1 shows the distribution of (1) people
based on ability (left: low ability, bottom; high ability, top) and (2) item difficulty
(right: easy, bottom; hard, top). The range of the distribution was 11 logits with
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the mean ability of our sample (-0.58 SE 0.38) below the mean difficulty of the
items (anchored at 0) indicating the model adequately matched our participants’
confidence. We did not have a ceiling effect (no individuals had a maximum
score) and observed negligible floor effects (4 individuals had a minimum score
[0.9%]). In addition to the overlapping items in Figure 1, we found occurrences
where item measures were within 2 standard errors of another item indicating
several items have overlapping difficulty. Item measures and standard errors are
presented in Table 3.

(Insert Figure 1)

Separation Index
The ABC scale differentiated individuals in our sample into 5.28
statistically distinct strata (separation index= 3.71).

DISCUSSION
This is the first study to examine ABC scale psychometrics using Rasch
analysis for individuals post-stroke. We found the Rasch model strongly supports
the use of the ABC scale to measure balance confidence in these individuals.
Like previous studies18, 20, we found the scale fit the Rasch model better using a
collapsed 5-category rating-scale. Collapsing the rating-scale corrected its
disorder and prevented items misfit. We found the ABC scale was adequately
unidimensional to meet the necessary assumption for Rasch analysis. Although
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EFA suggested a second factor, we do not feel that it is warranted provided (1)
the improvement in model fit is minimal, (2) the eigenvalue ratio for the first and
second factors greatly exceeds the recommended value of 4, and (3)
visualization of the scree plot confirms one dominant factor. Also, there is no
clinical rationale to support items grouped in the second factor except for the fact
they are the more difficult items on the scale. Therefore, there is not enough
evidence that unidimensionality is violated, which is consistent with previous
publications.17-20 Our analysis of local dependence identified three item pairs with
residual correlations greater than 0.2 magnitude. One recommendation is to
remove items with high dependence when performing Rasch analysis because
item dependence can be a threat to unidimensionality.25 However, there is a
discrepancy as to what magnitude of association constitutes removing items.19, 25
Therefore, we reported results with all items under the caveat that effects of local
dependence should be closely evaluated when translating the ABC scale into a
computerized-adaptive test because item pairs with local dependence may need
to be identified as “enemies”.25
We found other similarities and only minor differences in the ABC scale’s
psychometrics for individuals post-stroke compared to other populations. We
report a separation index (3.71) for the ABC scale indicating that the scale
separated our sample into 5.28 statistically distinct strata based on balance
confidence, similar to previous publications (5.220, 417). Other congruent
psychometrics include high Cronbach’s alphas (0.9418, 0.9519, 0.9320, 0.95 in our
study) and no floor or ceiling effects.17, 18, 20 The range of the scale in our model
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was 11 logits (-6 to 5), which was comparable to other publications.17-20 The three
items; “walk outside on an icy sidewalk”, “standing on a chair and reaching for
something”, and “step onto or off an escalator while holding onto parcels such
that you cannot hold onto the railing” are consistently (with the exception of
order) the three most difficult items.17-20. However, there is more variability in item
difficulty for easy items. We found the item “getting into or out of a car” to be the
easiest item, which is comparable with two publications where this item was the
second easiest18, 20. Yet, in other publications this item was considered
moderately difficult and fell close to the center of the scale.17, 19
A component of validating measurement scales derived from Rasch
analysis is to determine whether the item hierarchy is consistent with clinical and
theoretical expectations.19 The item hierarchy in Table 3 and Figure 1 show item
difficulty progress from discrete stable tasks (i.e, reaching and transferring) to
stable walking to walking tasks in conditions of increasing instability. Thus, item
hierarchy is consistent with clinical and theoretical expectations for individuals
post-stroke and more broadly, individuals with balance impairments.
Therefore, we can conclude that the ABC scale responds similarly for
individuals post-stroke and other populations including; community-dwelling
older-adults, outpatient orthopaedic physical therapy participants, individuals with
lower-limb amputation and individuals with Parkinson’s disease. As a result,
clinicians or researchers interested in measuring balance confidence for these
clinical populations do not need to develop diagnosis specific versions of the
instrument and can compare scores between patient groups. The ABC scale’s
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ability to respond similarly across a variety of patient populations supports recent
recommendations by the ANPT for the scale to be included in a core set of
outcome measures in the rehabilitation of adults with neurologic diagnoses21 and
allows one to hypothesize that the instrument may be “diagnosis free”.

IMPLICATIONS FOR FUTURE RESEARCH AND PRACTICE
We present two recommendations for future research and practice to
facilitate the clinical adoption of the ABC scale. First, we recommend
implementing a 5-category rating scale (“no confidence” [0], “low confidence” [1],
“moderate confidence” [2], “high confidence” [3], “complete confidence” [4])18.
Second, we recommend reducing the number of items by creating short-forms
and computerized-adaptive tests of the ABC scale based on the Rasch model.
Although, three short-forms exist for the ABC scale,29-31 they were not developed
from a Rasch model and should be approached with caution as they may have
diminished measurement characteristics relative to the full scale.19, 32
In general, these recommendations should facilitate clinical adoption of the ABC
scale by reducing test administration time, a commonly cited barrier to outcome
measurement use by practitioners.33, 34

STUDY LIMITATIONS
There are some limitations with this research. One limitation is that the
authors were not in control of the data-collection procedure, which is typical of
archival data secondary analyses. Selection bias associated with selection of
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acute care facilities for urgent stroke care may exist potentially limiting our
findings’ generalizability. Generalizability of our findings may also be limited by
the inclusion criteria required for individuals to participate in the LEAPS trial.
Specifically, participants in the trial were community dwelling and able to
ambulate indicating that our findings may not extend to more functionally limited
individuals.

CONCLUSIONS
Consistent with calls to use the ABC scale across neurologic diseases in
adult populations,21 Rasch analysis supports the use of the ABC scale for
measuring balance confidence in individuals post-stroke. The ABC scale’s
psychometrics are largely enhanced with a 5-category rating scale. We
recommend using the ABC scale to quantify balance confidence in these
individuals based on absent floor and ceiling effects and the scale’s ability to
distinguish 5 strata of individuals. Collapsing the ABC’s rating scale and
developing a computerized-adaptive test will enhance measurement capability
and efficiency for clinicians and researchers working in stroke rehabilitation.
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Table 1: Participant Demographics
n=406
Demographic Characteristics
ABC Score
(2 months
post-stroke)
Age
Sex
Male
Female
Race
American Indian
Asian
Black or African
American
White
Native Hawaiian
More than 1 race
Unknown

Totals
45.06% (23.88%)
61.97 (12.76)
54.93%
45.07%
1.23%
13.3%
22.17%
57.64%
4.68%
0.74%
0.25%

Hispanic or Latino

15.52%

Ischemic
Hemorrhagic
Uncertain

80.05%
18.72%
1.23%

Right Hemisphere
Left Hemisphere
Brainstem
Bilateral Hemispheres

48.03%
35.22%
62%
6%

Stroke Type

Stroke
Location

Continuous variables are presented in mean (standard deviation)
Categorical variables are presented as a percentage
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Table 2. Rating-Scale Structure
Score

Observed
Average

Outfit
Meansquare
1.07
0.84
0.78

Frequency Counts
(%)

-2.72
-1.32
-0.20

Infit
Meansquare
1.06
0.90
0.85

0 (no confidence)
1 (low confidence)
2 (moderate
confidence)
3 (high confidence)
4 (complete
confidence)

0.95
2.25

0.91
1.40

0.92
1.33

1400 (22%)
629 (10%)

1521 (23%)
1352 (21%)
1594 (25%)
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Table 3. Item Measure Order
Item

Item
Number

Measure

Model
Standard
Error

Infit
Meansquare

Infit
z-score

Outfit
Meansquare

Outfit
z-score

Point
Measure
Correlation

“walk outside on icy
sidewalks”

16

1.98

0.08

0.96

-0.4

0.94

-0.4

0.67

“stand on chair and
reach for
something”

6

1.79

0.08

1.29

3.4

1.10

0.8

0.65

“step onto or off an
escalator while
holding onto
parcels such that
you cannot hold
onto the railing”

15

1.45

0.07

1.00

0.0

0.93

-0.6

0.71

“are bumped into
by people as you
walk through the
mall”

13

0.49

0.07

0.73

-4.2

0.69

-4.1

0.80

“stand on your tip
toes and reach for
something above
your head”

5

0.43

0.07

1.04

0.6

1.02

0.3

0.74

“sweep the floor”

7

0.36

0.07

1.35

4.5

1.31

3.4

0.71

“step onto or off an
escalator while you
are holding onto a
railing”
“walk in a crowded
mall where people
rapidly walk past
you”

14

0.11

0.07

1.05

0.7

0.98

-0.2

0.76

12

-0.04

0.07

0.65

-5.7

0.62

-5.6

0.82

“walk up or down
stairs”
“bend over and
pick up a slipper
from the front of a
closet floor”
“walk up or down a
ramp”

2

-0.11

0.07

1.03

0.5

1.02

0.2

0.75

3

-0.27

0.07

1.01

0.1

0.97

-0.4

0.76

11

-0.44

0.07

0.81

-2.9

0.76

-3.4

0.80

“walk across a
parking lot to the
mall”
“walk outside the
house to a car
parked in the
driveway”

10

-0.51

0.07

0.88

-1.8

0.82

-2.4

0.80

8

-1.11

0.07

0.88

-1.7

0.84

-2.1

0.80

“walk around the
house”

1

-1.22

0.07

1.03

0.4

1.02

0.3

0.73

“reach for a small
can off a shelf at
eye level”

4

-1.35

0.07

1.23

3.0

1.26

3.0

0.73

“get into or out of a
car”

9

-1.56

0.07

1.21

2.8

1.14

1.7

0.71
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Figure 1. Person-Item Map
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Item abbreviations: Bumped while walking (Are bumped into as you walk in a
mall), Stand tip toes/reach overhead (Stand on tip toes and reach overhead),
Pick up a slipper (Pick up a slipper from the floor), Walk to car outside (Walk
outside to a car in the driveway)
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SUPPLIERS
a. Winsteps version 3.93; John Lincare, Beaverton, OR: Winsteps.com
b. SAS version 9.4; SAS Institute Inc. 100 SAS Campus Drive Cary, NC 27513
c. Mplus version 7.4; Muthén & Muthén 3463 Stoner Avenue Los Angeles, CA
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Abstract
Objective: Item-level psychometrics of the Functional Gait Assessment (FGA), a
measure of walking balance ability, have not been determined for persons with
chronic stroke and made available for clinical use. The objective of this study was
to evaluate the FGA’s unidimensionality, report item-level psychometrics and the
item hierarchy, and present an FGA ability map for clinical use to identify a
person’s measure and inform clinical decision-making.

Methods: We used retrospective response data from an NIH-funded center’s
shared research database containing 101 ambulatory persons with chronic
stroke. Factor analysis was used to evaluate unidimensionality and item local
dependence. Rasch analysis was used to examine rating-scale structure, item
and person fit, item hierarchy and separation index of the FGA.

Results: Confirmatory and exploratory factor analyses confirmed the FGA’s
unidimensionality and showed that none of the items had local dependence. The
category rating-scale advanced monotonically and met published criterion. The
item hierarchy was like that for community-dwelling older adults with mean ability
level of the sample slightly above the mean item difficulty (0.28 logits, 0.63
standard error). The FGA had high patient reliability (0.90) despite 3 items and
9.9% of the sample misfitting. The FGA did not have a floor or ceiling effect and
was able to separate people into 4 strata.
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Conclusions: Factor and Rasch analyses support the use of the FGA for
measuring walking balance ability in ambulatory persons with chronic stroke. An
FGA ability map can provide an instantaneous interval measure score for
patients while informing personalized treatment design and goal setting. Results
from this paper support clinical practice recommendations to use the FGA in
outpatient stroke rehabilitation and should address barriers to clinical
implementation.

Impact Statement: Item-level psychometrics and an FGA ability map provide
clinicians with an understanding of the item hierarchy and a way to inform
personalized treatment planning and goal setting. This should enhance clinical
utility by improving patient specific interpretation and facilitate adoption of clinical
practice guidelines in stroke rehabilitation.

Keywords: stroke, gait, balance, measurement – applied
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Introduction
Measurement of walking ability is a necessary component of stroke
rehabilitation. The Functional Gait Assessment (FGA) is a standardized clinical
scale that was developed to measure a person’s ability to maintain balance while
walking.1 The FGA consists of 10 items that measure an individuals’ performance
across a span of daily walking tasks that vary in difficulty. Items are scored using
a 4-category rating-scale by a clinician observing an individual perform the tasks.
An overall FGA score is calculated by summing the items’ scores.
Conventional psychometric properties of the FGA have been reported for
persons with chronic stroke.2, 3 The FGA has excellent test/retest (ICC=0.95)3,
interrater (ICC=0.94)2 and intrarater (ICC=0.97)2 reliability and has strong
correlations (r>0.7) with measures of mobility (i.e., Barthel Index, Rivermead
Mobility Index), walking (ie. gait speed, Functional Ambulatory Category), and
balance ability (i.e., Berg Balance Scale).2 Similar psychometrics have also been
reported for other patient populations including community-dwelling older adults4,
persons with vestibular disorders1, and Parkinson’s disease5, 6. This similarity
across a clinical diagnoses commonly seen in outpatient neurologic rehabilitation
resulted in the American Physical Therapy and Academy of Neurologic Physical
Therapy’s joint Clinical Practice Guideline recommendation for the FGA to be
used as part of a core set of outcome measures.7 Yet, there are still several
barriers cited by clinicians for not using standardized measures. Several barriers
reference clinical utility of measures including time (administration time is
lengthy, requires more time than information is worth), lack of clinical relevancy
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(information is too subjective, items are not relevant to the patient), and limited
interpretability (difficult to interpret, does not contribute to the plan of care).8, 9
However, rather than disparage physical therapists for not using
standardized measures, efforts should be focused on improving the usefulness of
standardized measures for practicing clinicians, especially since individual test
scores appear to have little value to the clinical reasoning process.10, 11 Rasch
analysis is one way to approach this problem since it generates item-level
psychometrics and item difficulty hierarchies that can inform clinicians about an
individual patient’s ability level and how they will perform across items of various
challenges on the assessment. The Rasch model uses a probabilistic
relationship between a person’s ability level and the item difficulty, with persons
having a high probability of successfully completing items that are easier than
their ability level and low probability of success on items that are harder than
their ability.12 A persons’ ability level is determined when person ability matches
item difficulty (when the patient has 50 percent probability of passing an item at a
particular rating). This offers several benefits for clinicians including improved
measurement efficiency and score interpretability by identifying where a patient’s
ability falls along a continuum.
Clinicians can take advantage of this improved clinical utility by using a
keyform. Keyforms were first introduced by Linacre13 as a Rasch informed score
sheet for generating “instantaneous” measurement values on an interval scale
from a person’s performance or response to items. In addition, keyforms visually
depicts a patient’s response pattern in relation to the item difficulty hierarchy.
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This allows a keyform to be used as an ”ability map” for physical therapists to
identify ideal tasks for treatment targets in both short- and long-term care
plans.10, 14-17 Physical therapists will be able to quickly glance at a completed
ability map to see what tasks the patient has mastery over, what tasks the patient
is making progress towards mastery, and what tasks the patient demonstrates a
poor ability to accomplish. Over time as a patient progresses through
rehabilitation, the ability map should show that the patient is gaining mastery over
more difficult items on the hierarchy.
A previous Rasch analysis of the FGA reported item-level psychometrics
for community-dwelling older adults.18 They showed the FGA was
unidimensional, had an ordered rating-scale structure, and had a clinically valid
item difficulty hierarchy. However, the primary findings were intended to
demonstrate the FGA removed previous DGI ceiling effects. Since there is
professional organizational support for the use of the FGA in adult neurological
populations there is need to examine the item-level psychometrics in common
neuropathology, such as stroke. This is needed because the performance-based
rating-scale used in the FGA could result in a different item hierarchy for
individuals with stroke due to lasting gait and balance impairments that are not
commonly found community dwelling older-adults. Additionally, development of
an FGA ability map may support the scale’s ability to inform clinical decision
making with respect to treatment design. Thus, the purpose of this study was to
examine the item-level psychometrics and item difficulty hierarchy of the FGA
and to create an ability map for clinical use. We provide an illustration for how
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ability maps can be used for informing clinical decision making with regards to
treatment planning and lend interpretability to FGA scores.

Methods
Data Source
We used a database that included research participants who participated
in studies at the NIH Center for Biomedical Research Excellence in Stroke
Recovery at the Medical University of South Carolina. The shared collective
database contains demographic information and research records for individuals
who consent to having their information archived for future use and is approved
by the Medical University of South Carolina’s Institutional Review Board.
Data for 101 individuals post-stroke was available for analysis. The date of
FGA data collection was used to calculate age and time since stroke (months),
and to link lower extremity Fugl-Meyer scores and overgound self-selected
walking speed. Participants completed the FGA without an assistive device or
orthotics. An aircast was permitted for severe ankle instability on the paretic leg
to prevent injury. Trained physical therapists and research staff oversaw and
scored all participants. Demographic data was analyzed with SAS [version 9.4;
SAS Institute, Cary, NC, USA].

Rasch Analysis
Rasch analysis of the FGA was completed using Winsteps [version 3.93.1;
John Lincare/Winsteps.com, Beaverton, OR, USA]. Tests of unidimensionality
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and local dependence were performed in R [version 3.6.1; R Foundation for
Statistical Computing; Vienna, Austria]19 with the following packages: ‘lavaan’20,
‘psyc’21, and ‘polycor’22.

Rating-Scale Structure
The rating scale structure was evaluated against Linacre’s three essential
rating-scale criteria23; (1) a minimum of 10 observations per rating-scale
category, (2) rating-scale category average measures advance monotonically
(i.e., demonstrate increasing item difficulty with increasing category value) and
(3) outfit mean-squares are less than 2. If the rating-scale did not meet
designated criteria we would apply modifications to best fit the criteria before
continuing the analysis.

Unidimensionality
The Rasch model assumes that the measure is unidimensional. We
performed a one-factor confirmatory factor analysis to test unidimensionality.
Model fits was assessed against recommendations from Reeve et. al., 2007:24
(1) comparative fit index >0.95, (2) root mean square error approximation <0.06,
(3) Tucker-Lewis Index >0.95, and (4) standardized root mean residuals <0.08. If
a one-factor model did not meet all the recommendations, we performed an
exploratory factor analysis to determine if additional factors could be identified.
We evaluated results from the exploratory factor analysis using Reeve’s
recommendations24 for model fit, eigenvalue ratio between the first and second
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factors (greater than 4 indicates sufficient unidimensionality), and clinical
interpretation.

Local Dependence
Local independence of items assumes that there are no significant
associations among item responses when controlling for the measure’s dominant
factor.24 We used a residual correlation matrix from a one-factor confirmatory
factor analysis to test for local independence and identify dependent item pairs. If
residual item correlations were >0.2 or <-0.2 we considered those items to be
locally dependent.24

Item and Person Fit
We evaluated the fit of items and persons to the Rasch model. Items or
individuals were labeled as misfitting when fit statistics for outfit had mean-square
standardized residuals greater than or equal to 1.4 and standardized z-scores
greater than or equal to 2.23, 25

Item Difficulty Hierarchy
We used the item difficulty hierarchy evaluate the FGA’s theoretical
construct validity and to test the extend that item’s overlapped. We considered
items to be overlapping if measure estimates for any two items were within 2
standard errors.
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Person-Item Match
The person-item map was used to evaluate for floor and ceiling effects.
We required that greater than 15% of individuals scored the worst or best
possible outcomes to consider the FGA to have a floor and/or ceiling effect.26

Separation Index
We used the person separation index to quantify how well the FGA can
differentiate people into statistically distinct strata. The following formula was
used to calculate the number of strata27:

Strata = [4*(person separation index)+1]/3

Ability Map Development
A keyform score sheet was generated using the results from the Rasch
analysis and is presented in Figure 1. The keyform shows the item hierarchy on
the right vertical axis. Items progress from hardest to easiest with the hardest
item at the top of the list. Items that are clustered together to show that these
items have overlapping or similar difficulty. The clusters are separated by a blank
line. The x-axis shows the interval-level measurement scale. The scale has been
converted from logits to the original scoring to enhance clinical interpretation. The
row for each item contains the possible category-rating scores: 0=severe
impairment, 1=moderate impairment, 2=mild impairment, and 3 = normal.
Clinicians can print the keyform score sheet and circle the rating for each item.
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The clinicians can then draw a vertical line through the bulk of the circles to
identify the patient’s score on an interval scale.13 We separated our sample into
tertials to represent high, moderate, and low ability. We used a randomly
selected individual from each tertial to demonstrate how the ability maps can be
used in the clinic. Each representative individual’s fit statistics were evaluated to
ensure that they fit the Rasch model.

(INSERT FIGURE 1)

Role of the Funding Source
The funding sources for this research played no role in the design, conduct or
reporting of this study and findings.

Results
The average age for our cohort was 58.6 years old (SD 12.6). We had 44
females (43.6%) and 42 individuals with left hemiparesis (58.4%). Mean lower
extremity Fugl-Meyer score was 25.2 (SD 0.29) and mean overground walking
speed was 0.76 m/s (SD 0.29). The average raw score for the FGA was 15.7 (SD
6.1). Descriptive statistics for our sample are presented in Table 1.

(INSERT TABLE 1 HERE)

Rating-Scale Structure
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The FGA’s current 4 category rating-scale fit the Rasch model well and
satisfied each of Linacre’s criteria23. Each category on the rating-scale had more
than 10 observations with outfit mean square values less than 2.0 and average
category measures advanced monotonically. Rating-scale structure results are
presented in Table 2.

(INSERT TABLE 2)

Unidimensionality
A one-factor confirmatory factor analysis had the following fit statistics; (1)
comparative fit index 0.98 (>0.95 indicates good fit), (2) root mean square error
approximation 0.11 (<0.06 indicates good fit), (3) Tucker-Lewis Index 0.98 (>0.95
indicates good fit), and (4) standardized root mean residuals 0.07 (<0.08
indicates good fit). Since our sample is below 250 participants, the root mean
square error approximation may not be an appropriate criterion for assessing
model fit since it is sensitive to sample size.28 To verify our findings, we ran an
exploratory factor analysis to assess for other potential factors. The exploratory
factor analysis recommended one factor and returned only one eigenvalue above
1. The eigenvalue ratio between the first and second factors was 8.9
(eigenvalues: factor 1 = 6.85, factor 2 = 0.77) with values greater than 4
supporting unidimensionality. Overall, the results from the exploratory factor
analysis did not support exploring a second factor and we concluded that the
FGA meets the unidimensionality assumption for Rasch analysis.
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Local Dependence
No item pairs were found to have local dependence.

Item and Person Fit
The FGA has high person reliability (0.90) and a Chronbach’s alpha value
of 0.92). Three items; 1) gait with narrow base of support, 2) gait with eyes
closed, and 3) gait and pivot turn and ten individuals (9.9%) responses met the
criteria for misfitting the Rasch model (outfit mean-square standardized residuals
greater than or equal to 1.4 and standardized z-scores greater than or equal to
2.23, 25). We removed missing fitting persons in serial order (most misfitting to
least misfitting) reanalyzing the data to test the effect of the unexpected
individual responses on overall fit of the items. Removing misfitting persons did
not improve the fit of the 3 misfitting items against our criteria. Item fit statistics
are presented in Table 3.

Item Difficulty and Person-Item Match
The item difficulty analysis is presented alongside item fit statistics in
Table 3. The FGA’s hardest item was “gait with narrow base of support” while the
easiest item was “gait and pivot turn”. The full hierarchy is presented in Figure 2
(Person-Item map).

(INSERT TABLE 3)
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The Person-Item map shows the distribution of (1) people based on ability
(left: low ability, bottom; high ability, top) against item difficulty (right: easy,
bottom; hard, top) for each item rating-scale score (0, 1, 2, and 3). The range of
ability levels on the FGA was 20 logits. The FGA did not have a ceiling or floor
effect because no individuals had a minimum score and only 2 (2%) had a
maximum score. Our sample’s mean ability level was 0.28 logits (0.63 standard
error) which is slightly above the mean difficulty level of the items (anchored at 0
logits). This indicates that the Rasch model adequately matched the walking
balance ability of our participants.
Table 3 presents item measures and standard errors. Several items
overlap in their coverage of the FGA’s scale. This can be seen on the keyform
score sheet (Figure 1) by relatively comparing the coverage of an item (i.e.,
range of categories on the rating scale) along the measurement scale to other
items. This effect is also visible on the Person-Item Map (Figure 2) when
determining the expanse of coverage for an item. For example, the item Gait
Level Surface covers the expanse of -4 to 5 logits depending on the rating score.

(INSERT FIGURE 2)

Separation Index
The FGA differentiated our sample into 4.31 distinct strata with a
separation index of 3.01.
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Ability Maps
Figure 3 shows the completed FGA ability maps for our three
representative individuals with low (3a), moderate (3b), and high (3c) walking
balance ability. Actual scores for each item are circled. The solid vertical line
traveling through the “bulk” of the items represents the patients score on an
interval scale and the dashed vertical lines show two standard errors around this
score.13 Visualizing the response pattern to the item difficulty hierarchy provides
an additional understanding of the persons score relative to their ability. In Figure
3a., which represents a person of low ability (score of 10; SE 1.17), this person
shows mild impairment (i.e., 2) with the easiest item followed by moderate
impairment (i.e., 1) on the next several items and eventually receiving severe
impairment (i.e., 0) ratings for the hardest items. In Figure 3b., which represents
a person of moderate ability (score of 15; SE 1.12), this person had a normal
(i.e., 3) rating for the easiest item, primarily mild impairment (i.e., 2) ratings for
the next cluster of items, moderate impairment (i.e., 1) for the next 4 items,
followed by severe impairment (i.e., 0) for the most difficult item. In Figure 3b.,
which represents a person of high ability (score of 22; SE 1.30), this person
obtains a normal (i.e., 3) rating for the first 5 items, begins to fluctuate between
mild impairment (i.e., 2) and normal (i.e., 3) on the next three more difficult items,
and then receives mild (i.e., 2) and moderate (i.e., 1) impairment for the two most
difficult items. A dashed box around items presents “treatment targets”. These
items reflect challenges that are near the patient’s ability level, identified as
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ratings to the left of the black vertical line. These items reflect the next set of
tasks the patient should gain mastery over as their ability level improves and the
black line shifts to the right.

(INSERT FIGURE 3)

Discussion
This study evaluated the unidimensionality and measurement properties of
the FGA using factor and Rasch analyses in persons post-stroke. Our results
from this study provide support for the use of FGA in outpatient settings for
assessing ambulatory individuals with chronic stroke as recommended by clinical
practice guidelines. Factor analyses supported the unidimensionality of the FGA,
implying the FGA is only measuring one construct, in this case, walking balance
ability. Rasch analysis findings demonstrate that the FGA’s rating scale structure,
item difficulty hierarchy, and no floor or ceiling effect was sufficient for measuring
a wide degree of walking balance ability on an interval scale in our sample,
ambulatory persons with chronic stroke representative of individuals receiving
outpatient physical therapy for walking balance related deficits. To our
knowledge, this is the first study examining the measurement properties of the
FGA for this patient population and the first to present an ability map for clinical
use.

Item hierarchy, rating-scale structure, model fit
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Ideally a measurement scale has sufficient items to assess the breath of
difficulty for a specific construct and those items follow a difficulty hierarchy
consistent with clinical and theoretical expectations.29 The FGA’s item difficulty
hierarchy was previously analyzed using Rasch analysis in a sample of
community-dwelling older adults18 and had the benefit of being compared against
the Dynamic Gait Index (DGI),30-32 the FGA’s predecessor.1 Historically, the DGI
had a logical order to the item hierarchy with easier items requiring less postural
adjustments to perform the tasks and increasing item difficulty by adding
additional task demands. The FGA’s hierarchy is similar to the DGI, however,
there is an exception with the item Gait Level Surface appearing at the middle of
the hierarchy.18 This may appear surprising because walking on a level surface
without perturbations should theoretically be the easiest item. Possibilities for this
finding could be related to the rating-scale structure or performance criteria.
Beninato et. al. hypothesized that the reordering of item difficulty observed
between the FGA and DGI was linked with the performance criterion used to
assign a person a category on the rating-scale rather than poor rating-scale
structure.18 When we examine the category descriptions used as criterion for
scoring there are several instances across items where individuals may have
more difficulty reaching higher scores because of lasting sensorimotor deficits
that are present with stroke pathology. Persons post-stroke are likely to have a
difficult time obtaining higher than a 2 on the item Gait Level Surface because a
3 requires that the patient walk faster than 0.85 m/s without gait deviations or an
assistive device. This contrasts with the item Gait and Pivot Turn, the easiest
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item on our hierarchy, where ratings are not dependent on speed or gait
deviations. This could explain some variation in item difficulty order between the
community-dwelling older adult cohort previously studied, however, except for
the easiest item difficulty was not starkly different. This may suggest the potential
for the FGA to be “diagnosis free” and measurements could be interpreted
similarly across diagnostic groups.
We found three items and approximately 10% of our sample misfit the
Rasch model. It is expected data will depart from the model to an extent, with the
question becoming ‘How much is tolerable?’.25 A few misfitting people are
unlikely to have a concerning impact on item-level psychometrics while a
misfitting item may point to more important problems with unidimensionality, test
administration, scoring, or definition of an item.24, 25 Unfortunately, there is not a
standardized approach to address misfit.24 We report the fit statistics using the
whole sample, rather than remove misfitting persons since; 1) removing misfitting
persons did not improve the model fit and subsequent interpretation of
measurement information from the FGA and 2) 10% or less individuals misfitting
the model reflects the high degree of heterogeneity in this patient group. We left
the misfitting items in our analysis for three reasons: 1) the FGA is
unidimensional and there was no local dependence among items, 2) it has been
suggested that mean-square values for items based on clinical observation can
be higher than patient-reported scales (up to 1.7; meaning no FGA items
misfit)25, and 3) further evaluation of the items and their scoring criteria does not
suggest they are measuring a different construct.24
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Ability maps and their implications for clinical practice
The Rasch methodology provides an innovative way to approach clinical
use of standardized measures with ability maps. Ability maps provides a way for
clinicians to use Rasch informed interval scaling while visualizing the relationship
between the patient’s measure and ability.10, 11, 13 Visualizing this relationship
gives meaning and interpretability to an individual patient’s score because
clinicians can see items the patient has mastery over, are gaining mastery, and
have no mastery. We identified items where the patient was rated just below their
ability level to represent treatment targets. These items can be thought of as a
“just right challenge” because should not be too easy or too difficult for the
patient to complete while still challenging their ability level. These items can
inform personalized short-term goals because they represent the next attainable
ability level the patient should gain mastery over in rehabilitation (i.e., when their
score shifts right with improvement).10, 14-16 Ability maps can also be used over
time to track progress and demonstrate a patient is gaining mastery over new
functional tasks with increasing FGA scores.

Implications for future research
The degree of overlap between items (Figure 2) demonstrates the
potential for the FGA to become a performance-based computerized adaptive
test (CAT). An FGA CAT would have two key benefits for clinicians; 1) it would
reduce test burden by requiring fewer items for measurement and 2) reduce
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administration time by providing clinicians with immediate knowledge of the
patient’s walking balance ability level.33-36
Another important consideration that is identified by our results is the
ability of the FGA to separate people into 4 distinct strata. Future work should
explore the characteristics of the strata and test the ability of the FGA to
separate persons into readily identifiable phenotypes using functional staging37, 38
that can be used to inform personalized care.39
Finally, pragmatic clinical studies are needed to determine if the added
information provided by the FGA ability map contributes to clinician goal setting
and treatment planning compared to scores generated from the traditional FGA.
These studies should also attempt to understand whether ability map help
address many of the clinician-reported barriers to using standardized measures
in practice.16

Limitations
There are several limitations to this study. First, we relied on retrospective
data of higher functioning individuals with chronic stroke associated with one
research site which can limit the generalizability of research findings. Second,
measures and treatment target zones derived from an ability map are estimates
and have sources of uncertainty. First, ratings are probabilistic in nature, not
absolute, so they can fluctuate due to rater, patient, and environment factors.
Next, the difficulty hierarchy of the items suggest that items are of increasing
challenge but do not reflect the “measurement” distance between the items. 10, 13
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Lastly, there is added error in measuring ability levels at the extremes of the
scale. Rasch measures corresponding to zero and perfect raw scores have
infinite standard errors.40 Infinite error is impractical to deal with in clinical
practice so scales are slightly adjusted on the ability map when converting from
the logit scale back to raw scoring. This is why the scale on the ability map is
from 2 to 2941 Despite these limitations, the ability map is able to provide a rapid
estimation of a patient’s ability and provides more interpretability to scores. (e.g.,
the participants in Figure 3 a-b show clear differences in their scoring patterns).10

Conclusions
In conclusion, Rasch analysis supports the use of the FGA for measuring
walking balance ability in persons with chronic stroke. The FGA ability map
provides clinicians with a new way to use and interpret patient responses on the
FGA for clinical reasoning related to treatment design and goal setting that was
not previously available. The FGA ability map should aid in addressing barriers to
clinical use and promote the implementation of clinical practice guidelines for
stroke rehabilitation.
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Figure 1. FGA Keyform Score Sheet

A keyform score sheet can be used to create an FGA ability map to determine a
patient’s measurement value and informing clinical decision-making based on
that patient’s performance on each item of the FGA. The FGA keyform score
sheet is informed by the Rasch model and uses the interval scale scoring and
item difficulty hierarchy. The top and bottom axes represent the interval score
scale for the FGA. The logit scale produced by the Rasch model was converted
back to the raw scores for ease of interpretation. The rows of the FGA keyform
score sheet contains individual items with their category-rating scores. The items
go from easiest to hardest with the easiest item at the bottom. Items are
clustered by similar difficulty and each cluster is separated by a gray space. The
rating-scale categories remain the same from the original FGA instructions (ie.
0=severe impairment, 1=moderate impairment, 2=mild impairment, 3=normal). A
clinician can complete an ability map by circling the rating corresponding to a
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patient’s performance for each item. The interval measure can be determined by
drawing a vertical line through the “bulk” of the circles to the scale on the x-axis.
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Table 1. Participant Demographic Information
Total Number of Participants = 101
Age (years)

58.6 (12.6) [23-85]

Male (n=57)

56.4%

Female (n=44)

43.6%

Right Hemiparesis (n=59)

41.6%

Left Hemiparesis (n=42)

58.4%

Lower Extremity Fugl-Meyer

25.2 (5.5) [14-34]

Overground Self-Selected
Walking Speed (m/s)

0.76 (0.29) [0.11-1.4]

Functional Gait Assessment

15.7 (6.1) [6-30]

Rating-scale Categories
Item-Level Information

0

1

2

3

(1) Gait Level Surface

1

62

27

11

(2) Change in Gait Speed

3

34

41

23

(3) Gait with Horizontal Head Turns

2

30

50

19

(4) Gait with Vertical Head Turns

1

30

48

22

(5) Gait and Pivot Turn

0

18

52

31

(6) Step Over Obstacle

23

34

24

20

(7) Gait with Narrow Base of Support

60

19

14

8

(8) Gait with Eyes Closed

38

41

19

3

(9) Ambulating Backwards

3

44

38

16

(10) Steps

0

29

57

15
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Continuous variables are presented as mean (standard deviation) [range]
Categorical variables are presented as a percentage
Overground walking speeds were collected without use of an assistive device or
orthotic unless an aircast was used to prevent ankle injury.
Frequency counts are provided for each category of the rating-scale per
individual item on the FGA
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Table 2. FGA Rating-Scale Structure
RatingScale Score

Observed
Measure
Average

Infit
Meansquare

Outfit
Mean-square

Frequency
Count (%)

0

-3.53

.98

.98

131 (13%)

1

-1.17

.84

.81

341 (34%)

2

1.32

.95

1.18

370 (37%)

3

3.30

1.21

1.19

168 (17%)
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Table 3. Item Measure Order
Item

Item
Number

Measure
Estimate

Standard
Error

Infit
Meansquare
(z-score)

Outfit
Meansquare
(z-score)

Gait with Narrow
Base of Support*

7

3.17

Gait with Eyes
Closed*

8

Step Over
Obstacle†

Point
Measure
Correlation

0.21

1.78
(4.4)

1.52
(2.4)

0.75

2.48

0.20

1.60
(3.8)

1.54
(3.1)

0.64

6

0.55

0.18

1.10
(0.7)

1.10
(0.8)

0.86

Gait Level Surface†

1

0.31

0.18

0.63
(-3.1)

0.64
(-2.9)

0.80

Ambulating
Backwards

9

-0.34

0.19

0.73
(-2.1)

0.74
(-2.0)

0.79

Change in Gait
Speed†

2

-0.93

0.19

0.83
(-1.3)

0.82
(-1.3)

0.78

Gait with Horizontal
Head Turns†

3

-1.00

0.19

0.83
(-1.3)

0.82
(-1.3)

0.74

Steps†

10

-1.03

0.19

0.78
(-1.7)

0.92
(-.5)

0.71

Gait with Vertical
Head Turns†

4

-1.18

0.19

0.75
(-1.9)

0.74
(-2.0)

0.77

Gait and Pivot Turn*

5

-2.04

0.20

0.98
(-0.1)

1.52
(2.7)

0.65

* Indicates a misfitting item
† Indicates an overlapping item
Items are presented in difficulty order to show their hierarchy with the hardest
item first followed by items in decreasing level of difficulty
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Figure 2. Person-Item Map

Figure 2 presents the distribution of ability levels (ie. walking balance ability) for
our sample to the left of the black line. To the right of the black line, the items are
presented in a hierarchy from most difficult (top) to least difficult (bottom). The
hierarchy is repeated based on the highest probability of person receiving a
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specified score for an item (0, 1, 2, or 3) corresponding to their ability level. This
part of the figure can be used to predict a person’s score for each item based on
their ability level by extending a horizontal line across the figure at a given ability
level. Persons will be most likely to receive the highest available score for an
item that is at or below their ability level.

For example, a person with an ability level of 0 logits (approximately the mean
ability level) would have the highest probability of scoring a 0 on the items Gait
with Narrow Base of Support and Gait with Eyes Closed, a 2 on the item Gait
Pivot and Turn, a 1 on all remaining items. Similarly, a person with an ability level
of 4 would be most likely to score a 1 on the item Gait with Narrow Base of
Support, 2 on Gait with Eyes Closed, Step Over Obstacle, Gait Level Surface
and 3 on Ambulating Backwards and all remaining items.
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Figure 3. Examples of FGA ability maps for clinical measurement and decisionmaking
3a. Person with Low Ability [Person Measure = 10; standard error = 1.17]

3b. Person with Moderate Ability [Person measure = 15 ; standard error = 1.12]
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3c. Person with High Ability [Person measure = 22; standard error = 1.30]

Completed FGA ability maps are presented for a representative individual with
low (3a.), moderate (3b), and high (3c) walking balance ability. The persons true
ability level (determined by the Rasch model) is presented by a solid vertical line.
The standard error associated with the person’s ability level is presented as two
dashed vertical lines. Circles are placed around the individual’s rating-scale
score for each item. The rating-scale from 0-3 matches the original rating-scale
used with the FGA. Clinicians can obtain the person’s measure by drawing the
vertical lines through the “bulk” of the circles. Items that represent treatment
targets are represented by a short-term goal planning box. These items are
reflective of challenges to walking balance ability that are not too easy or difficult
for the patient and are ideal treatment targets. The treatment target range should
shift up as patient’s progress in rehabilitation and gain mastery over skills below
their ability level (i.e., left of the black line).
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Abstract
Interpreting change is a requisite component of clinical decision making for
physical therapists. Physical therapists often interpret change using Minimal
Detectable Change (MDC) threshold values. Current MDC threshold formulas
are informed by Classical Test Theory and calculated with group-level error data.
A Classical Test Theory approach assumes measurement error is the same
across the entirety of the measure’s scale and confines the MDC to the sample
characteristics of the study. An item response theory informed approach
accounts for variability in error by converting ordinal scales into interval
measures based on latent trait ability that have their own associated error
estimates. Error estimates at the measure-level can be used to determine a
conditional minimal detectable change (cMDC) threshold for individual patients
based on their unique pre- and post-score combination. cMDC thresholds can
provide clinicians with a means for using individual score data to interpret change
scores. cMDCs provide a personalized approach that should lower the threshold
for change compared to the MDC and enhance precision of care decisions by
preventing misclassification of patients. The purpose of this perspective paper is
to present how principles of item response theory and findings from a Rasch
analysis can address MDC thresholds limitations for informing clinical practice.
We demonstrate how a conditional minimal detectable change (cMDC) threshold
can be generated from item-level psychometrics derived from the Rasch model
using the patient-reported Activities-specific Balance Scale (ABC) commonly
used in stroke rehabilitation. We also illustrate how the cMDC compares to the
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MDC when accounting for changes in measurement error across a scale. With
theoretical patient examples, we highlight how reliance on the MDC can result in
misclassification of patient change and cMDCs can help prevent this from
occurring. This personalized approach for interpreting change can be used by
physical therapists to enhance precision of care decisions.

Keywords: stroke, balance, measurement – applied
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Introduction
Precision rehabilitation requires that physical therapists accurately
interpret a patient’s change over time to make appropriate clinical decisions such
as whether an intervention is efficacious. Standardized measurement tools can
be used to quantify a patient’s change by calculating the difference between a
pre-intervention and post-intervention scores. However, the clinical meaning of
change scores is not intuitively apparent for physical therapists.1, 2 Physical
therapists need to be able to understand the responsiveness of the measure to
interpret whether the change scores are reflective of detectable change.
Responsiveness of a standardized measure is commonly quantified with a
minimal detectable change (MDC) threshold. MDC thresholds represent the
amount of change needed to exceed measurement error for a specific measure
and are calculated with an accompanying confidence interval.3-5 For example, an
MDC threshold with a 95% confidence interval (MDC95) equal to 15 points means
that 95% of individuals who are unchanged will have a random fluctuation in their
scores on pre- and post-tests up to 15.6 Clinically, this means a patient would
need to change greater than 15 points to have a detectable change that exceeds
measurement error, regardless of their initial and final scores. The ability to have
a threshold for establishing “real” change on a measurement tool holds a great
deal of clinical benefit because physical therapists can easily identify whether
patients benefit or not from treatment and inform care decisions.
However, there are downsides to using MDC thresholds stemming from
underlying assumptions that limit the clinical interpretation and application for

123
physical therapists.1, 4 A primary concern with MDC thresholds is the reliance on
group-level error data to calculate the value. Group-level data is heavily
dependent on the characteristics of the sample used to quantify measurement
error.7 This means that MDC thresholds are sample specific, limiting the validity
of the MDC in situations where an individual patient is not entirely reflective of the
sample’s characteristics used to derive the change threshold. Group-level data,
also, assumes that error is consistent across the whole measurement scale.7
Measures in rehabilitation rarely have consistent error across the whole scale as
the precision is typically greater at midrange scores and less at the extremes.8
This means that detecting change is dependent on the error specifically
associated with an individual patient’s pre- and post-scores. Determining MDC
values from pre- and post-score combinations should be preferable because it
may improve (i.e., lower) a measurement tool’s threshold for responsiveness,
especially when patients have scores near the midrange of the scale.4, 9 More
precise thresholds could help prevent physical therapists from making
inappropriate care decisions that result from misclassifying change in patients.
This method also promotes a more personalized approach to rehabilitation by
allowing physical therapists to interpret change from individual-level data.
The downsides to MDC thresholds were somewhat apparent when the
concept was initially introduced into physical therapy practice by Stratford and
colleagues.4 Stratford and colleagues hypothesized that a more precise
approach for determining change thresholds could come from individualizing
MDC values to the error associated with a person’s specific initial and final score
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combinations, also known as a conditional minimal detectable change (cMDC).4
This conditional approach to calculating an MDC threshold should address
concerns with changes in error across a measurement scale and allow physical
therapists to use individual-level data to make personalized decisions regarding
change for patients. The idea of using cMDC thresholds did not initially take hold
largely because of the classical test theory approach to measurement and error.
Typically, classical test theory has been used in measurement to explain the
patient’s overall score into two parts: 1) the true score and 2) error. This
approach gives an understanding of the construct for the whole instrument (total
score) but relies on group-level data error making it difficult to calculate cMDC
thresholds.7 While there are now mathematical formulas for deriving cMDC
thresholds under classical test theory approach, the calculations are intensive
and resulting values can be hard to interpret when scales are ordinal.4, 9
One way to overcome challenges with classical test theory is to use an
item response theory model to generate cMDC thresholds.9 Item response theory
models, like the Rasch model, examine the individual item fit to the measurement
model by examining the probabilistic relationship between a person’s ability and
the difficulty of the item.10 For example, persons should have a high probability of
doing well on items less difficult than their ability levels, a low probability of doing
well on items that are more difficult than their ability level, and a 50% probability
of doing well on items that are at their ability level. When measures fit the Rasch
model, an item difficulty hierarchy (i.e., easy to hard item difficulty ordering) can
be generated with a linear, interval measurement scale.10 This scale is
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independent of the sample and allows a level of precision, standard error, to be
generated for every person measure available.8 The standard errors can be used
to quickly generate cMDC thresholds using a simple formula for every pre- and
post-score combination.9
The purpose of this paper is to demonstrate how cMDC thresholds can be
derived from Rasch informed measure-level error and to illustrate the benefits of
individualized detectable change thresholds using a common patient-reported
standardized outcome measure in stroke rehabilitation, the Activities-specific
Balance Confidence (ABC) scale. We will demonstrate how changes in error
across a scale comparatively affect cMDC and traditional MDC threshold
calculations. We will also use theoretical patient examples to illustrate how
reliance on a single threshold for detecting change can result in misclassification
and inappropriate clinical decision making compared to a personalized
conditional threshold, which we argue will enhance care precision.

Methods
Previous Rasch Analysis Findings
We previously performed Rasch analysis of the ABC scale using response
data from persons post-stroke in Winsteps [version 3.93.1; John
Lincare/Winsteps.com, Beaverton, OR, USA].11 Data for the ABC scale was
taken from the Locomotor Experience Applied Post-Stroke (LEAPS) trial and
included 406 individuals approximately 2-months post-stroke.12
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Results of the Rasch analysis for the ABC scale showed that the original
rating-scale structure did not adequately fit the Rasch model because many of
the categories in the rating-scale (i.e., 0-100%) were underused. We addressed
this issue by collapsing the rating scale to 5 categories: no confidence (0-9%),
low confidence (10-30%), medium confidence (31-60%), high confidence (6190%), full confidence (91-100%). Collapsing the rating-scale improved the fit of
the ABC scale to the Rasch model and generated item difficulty hierarchies and
item-level psychometrics that were similar to those found in other studied
populations.11, 13-16
Rasch analysis generates an interval scale using logits for person
measures that quantify a person’s ability level, in this case balance confidence,
and each person measure has a standard error (SE). The logit scale is anchored
with a mean value of 0 and standard deviation of 1, which allows for negative and
decimal point values. The logit scale may confuse clinicians because the current
scoring for the ABC scale does not provide negative values or decimals. Logits
can be converted to different values by selecting a new anchor for the mean and
re-scaling the person measures.17 We converted persons measures and SE from
logits to a 100-point scale to mimic current scoring for the ABC scale and to help
with clinical interpretation.

Calculating MDC Thresholds
Group-level error data for the ABC scale was calculated using original
scores (i.e., prior to Rasch analysis) with the following formula18:
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Standard Error of Measurement (SEM) = Standard Deviation *√(1-Cronbach
Alpha)

The Standard Error of Measurement (SEM) was used to calculate an MDC
threshold with a 95% confidence interval (MDC95) with the following formula19:

MDC95 = 1.96*√(2)*(SEM)

Calculating cMDC Thresholds
We calculated cMDC thresholds with a 95% confidence interval (cMDC95)
for every possible pair of pre- and post-score combinations using the following
formula9:

cMDC95 = ([SEpre-score-SEpost-score]/2)*1.96*√(2)

Comparing MDC and cMDC Thresholds
We plotted all the cMDC95 thresholds associated with each patient
measure on the ABC scale to observe the effect of individual-level standard error
on detectable change across the measurement scale. In addition, we plotted the
MDC95 threshold to illustrate the differences between using a fixed and
conditional threshold for detecting change. We extracted three cMDC95 threshold
curves to show theoretical patient examples with an initial high (75), moderate
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(50), and low (25) measure and plotted the cMDC95 thresholds against change
scores to show when there are mismatches between cMDC95 and MDC95 for
determining patient change. We use these theoretical examples to show the
value of using cMDC95 thresholds to detect change in individual patients.

Results
Figure 1 shows a plot of all possible cMDC95 thresholds for each initial and
final measure combination compared to the MDC95 threshold. The x-axis
represents the patient’s final ABC measure. The y-axis represents the change
threshold value required for detectable change. Each line on the plot contains the
cMDC95 values associated with an initial measure value. A vertical line can be
draw up from the final measure value on the x-axis to where it intersects the line
associated with a person’s initial measure. The point of intersection on the y-axis
the associated cMDC95. The dash line, in Figure 1, represents the MDC95
threshold. Our MDC95 was 14.72, which is similar to those reported for the ABC
scale20, 21 in previous studies with persons post-stroke. The MDC95 threshold
dash line is fixed across the whole scale because it is not dependent on the
patient’s initial or final measures.
The cMDC95 changes across the scale because it is a function of the SE
associated with the initial and final measures. In the plot, each line has a fixed
initial measure and associated SE while the final measure and associated SE is
changing. The different heights for each line are reflective of the amount of SE
that is associated with the fixed initial measure value. Lines at the top of the plot

129
represent high or low extreme initial measures (i.e., 0 or 100). The lines begin to
move down towards the bottom of the plot as the initial measure value is closer
to mid-range of the scale because there is less SE associated with these scores.

(INSERT FIGURE 1 HERE)

Figure 2 contains three theoretical patient examples. Figure 2A. is for a
patient with a moderate initial measure value of 50, 2B. is for a patient with a low
initial measure value of 25, and 2C. is for a patient with a high initial measure
value of 75. Each of the three plots have the change score required for
detectable change on the y-axis and all possible change scores for that patient.
The blue dash line in each plot is the cMDC95 curve and the black dash line is the
MDC95 value. Detectable change based on the cMDC95 and MDC95 value can be
determined by comparing the x-axis value and the associated y-axis value for
each line (cMDC95 and MDC95). The patient has achieved a detectable change
when the x-axis value exceeds the y-axis value. Each plot also has a
Misclassification Zone. The Misclassification Zone represents a range of change
scores where there is a mismatch between the cMDC95 and MDC95 thresholds.
For example, in Figure 2A., the patient has initial measure of 50 and the xaxis represents change scores from 50 to 100 (max value on the scale). Change
scores from 0 to 6 (i.e., final measure values of 50-56) would not be considered
detectable change by the cMDC95 or MDC95, change scores from 7 to 14 would
be considered detectable change by the cMDC95 but not the MDC95 and change
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scores from 15 to 50 would be considered detectable change by both the
cMDC95 or MDC95. The range of change scores from 7 to 14 where there is a
mismatch in change detection by the cMDC95 or MDC95 creates the Zone of
Misclassification. Figure 2B. has the same pattern as 2A. The initial range of
change scores 0 to 8 is not considered detectable change by the cMDC95 or
MDC95. Change scores between 9 and 14 are considered detectable change by
the cMDC95, not the MDC95, and creates a Zone of Misclassification. Change
scores greater than 15 are then considered detectable change under both
thresholds. Figure 2C still displays a Zone of Misclassification, but the associated
alignment between cMDC95 and MDC95 thresholds is different. For this patient,
with a high initial measure value of 75, the change scores from 0 to 14 would not
be considered detectable change. However, change scores from 15 to 25 would
be considered detectable change with the MDC95 and not the cMDC95. In this
case, the relationship between the cMDC95 and MDC95 is reversed for the Zone of
Misclassification.

(INSERT FIGURE 2 HERE)

Discussion
The purpose of this paper was to demonstrate that cMDC thresholds can
be derived from a Rasch informed version of the ABC scale and to examine the
differences between an MDC and cMDC approach for detecting change using
theoretical patient examples. Our results show that cMDC thresholds can easily

131
be derived when patient measure-level data is available for a standardized
outcome measure. We were able to demonstrate how cMDC thresholds are a
function of the change in error across a scale with more error associated at the
extreme scores following a “u-shaped” trajectory.8 This feature allows cMDC’s to
generally reduce the threshold for detecting change in comparison to an MDC
threshold – particularly for persons with measures near the mid-range of the
scale. Our theoretical patient examples show that there are ranges of change
scores that fall into a Misclassification Zone where detectable change under the
MDC and cMDC are not in agreement. These examples highlight the benefits of
using individual-level data compared to group-level data for making
interpretations about unique patients. The examples also demonstrate how
patients are at risk of being misclassified as either changing or not changing
when using group-level data informed thresholds for detectable change (i.e.,
MDCs).
Misclassification of patients based on the MDC approach has wide
reaching implications for clinical decision making.9 In a broad sense, the most
concerning misinterpretation of change would be classifying a patient as having
plateaued or not responded to physical therapy treatment and ending an episode
of care when the patient had in fact made a measurable change. However,
misclassification of change also has implications for clinical decision making
related to treatment prescription. Physical therapists regularly make decisions to
manipulate variables related to treatment prescription to either progress patients
or regress them when a prescription has detrimental effects. Misinterpretation of
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change, positive or negative, could result in clinicians inappropriately altering the
volume, frequency, intensity, or mode of treatment. Regardless of whether these
inappropriate decisions have serious adverse events (i.e., over prescribing
treatment), treatment precision is lost, and individual patient outcomes suffer.
In addition to clinical applications, the use of cMDC vs MDC thresholds
has implications for research. Often MDC thresholds are used to determine
sample size, determine treatment efficacy, calculate measures used to inform
clinical decisions like number needed to treat, and serve as anchors for
identifying minimally important differences or minimally important clinical
differences.9, 22-25 Specifically, using an MDC threshold will likely cause samples
sizes to be overestimated, which may cause trials to not appear feasible because
of the required number of participants. In addition, MDC thresholds may cause
beneficial (or detrimental) treatment effects to be missed, especially when the
primary outcome is dichotomized based on whether a participant had a
detectable change. These implications are especially relevant in rehabilitation
studies where patient-reported or clinician-observed measures, instead of
laboratory measures, are the primary outcome. Researchers should consider
using item-response theory informed measures and cMDC thresholds to prevent
overpowering studies or inappropriately concluding that a treatment has no
effect.

Limitations and Future Directions
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There are still limitations to the cMDC approach despite the benefits of
using individual-level data. The primary limitation is that cMDC thresholds must
be more easily attainable to be commonly used by researchers and physical
therapists.26 There are a couple of ways to address this barrier. First,
standardized measures that use ordinal scales need to be informed by item
response theory methodology (e.g., Rasch analysis) to generate interval-level
scaling and measure-level precision estimates (i.e., standard error). This should
quell concerns about using ordinal level data for calculating MDC thresholds.26-29
Second, measure-level precision should be reported in item response theory
papers generating item-level psychometrics for generating cMDCs. This would
allow clinicians to be able to generate cMDC’s and provide researchers to with
access to error information for study design and statistical analysis planning.
Another limitation for adopting a cMDC approach is the fact each standardized
measure will have a change threshold for every possible score combination. It is
unlikely to expect clinicians to use cMDCs if they are not easily accessible in real
time, especially when the alternative is committing to memory a few MDC
thresholds that are relevant to common measures they use and patient
populations they treat. To address this concern, we recommend creating webbased calculators or apps that can integrate with electronic medical records to
rapidly generate an individual’s cMDC threshold in real time for clinical decision
making. These products also have potential to be integrated with electronic
versions of standardized measures, such as a computerized adaptive test, to
provide a real-time indicator to clinicians when patients have a detectable

134
change. Future studies should also aim to examine whether measure-level
precision estimates are unique to specific populations. It is feasible that some
standardized measurement tools may be “diagnosis-free” 11, but more research
in this area is necessary before applying cMDC’s across patient populations.
Also, while we have shown how cMDC’s work for a patient-reported outcome
measure, the Misclassification Zone may not be as large or display a similar
result for measures that already have appropriate rating-scale structure prior to
performing a Rasch analysis. We recommend that future studies examining the
differences between MDC and cMDC thresholds investigate the effect of ratingscale structure on error.
Lastly, clinicians should be aware that cMDC thresholds allow for the
detection of change beyond measurement error for individual patients but do not
attempt to inform whether that change was meaningful to the patient. There are
several proposed methods for assigning meaningfulness to change scores.1, 24, 25
However, many of these approaches utilize group-level MDC calculations and do
not allow for individual interpretation. We recommend that clinicians consider the
individual patient goals in relation to their overall function with the cMDC to make
clinical decisions regarding the “meaningfulness” of change until more empirical
methodology is presented to promote a more personalized rehabilitation
approach.

Conclusions
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In conclusion, cMDC thresholds can be easily generated from Rasch
informed measure-level precision estimates. These cMDC thresholds have
explicit benefits over the traditional MDC approach including the use of
individual-level data to inform change detection. The cMDC approach allows
clinicians to interpret change relative to their individual patients and greatly
reducing the opportunity for misclassifying change or no change. This is
especially true where clinicians are at risk of underreporting change for measures
in the middle of a scale and overreporting change at the extreme high end using
a traditional MDC. Clinicians can use cMDCs to provide a personalized view of
interpreting change that should enhance clinical decision making and precision
rehabilitation.

Role of the Funding Source
The funding sources for this research played no role in the design, conduct or
reporting of this study and findings.

Acknowledgements
We would like to acknowledge the LEAPS investigator team [Principal
Investigator: Pamela Duncan, PT, PhD, FAPTA, FAHA] for data collection and
archival. We also want to acknowledge the National Institute of Neurological
Disorders and Stroke for funding the LEAPS trial (R01 NS050506).

Authors Note

136
Data from the LEAPS trial can be obtained by contacting the National Institute of
Neurological Disorders and Stroke at www.ninds@nih.org

Funding
Partial funding for this project was provided by the VA Office of Research and
Development (ORD), with additional support from the VA/ORD Rehabilitation
R&D Service (1I01RX001935), support from the National Institutes of Health
(NIH P20 GM109040,) and the Promotion of Doctoral Studies Level I Scholarship
from the Foundation for Physical Therapy Research. Data for the study was
provided by the NIH National Institute of Neurological Disorders and Stroke from
the Locomotor Experience Applied Post-stroke (LEAPS) trial (R01 NS050506).

Any opinions expressed in this publication are those of the authors and do not
necessarily reflect the view of the U.S. Department of Veteran Affairs or the NIH.

Clinical Trial Registration:
Some of the data used in this study was collected from clinical trials registered at
ClinicalTrials.gov (NCT00243919).

Disclosures/Presentations
The authors report no conflicts of interest.

137
Partial findings from this manuscript were presented at the Medical University of
South Carolina’s Research Day in 2020. The full manuscript has not been
submitted for publication with any other journal.

138
References
1.

Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and
measures used in physical therapy. Physical therapy. May
2006;86(5):735-743.

2.

Velozo CA, Woodbury ML. Translating measurement findings into
rehabilitation practice: an example using Fugl-Meyer Assessment-Upper
Extremity with patients following stroke. Journal of rehabilitation research
and development. 2011;48(10):1211-1222.

3.

Riddle DL, Stratford PW. Is This Change Real? : Interpreting Patient
Outcomes in Physical Therapy. Philadelphia: F.A. Davis Company; 2013.

4.

Stratford PW, Binkley J, Solomon P, Finch E, Gill C, Moreland J. Defining
the Minimum Level of Detectable Change for the Roland-Morris
Questionnaire. Physical therapy. 1996;76(4):359-365.

5.

Stratford PW, Binkley JM. Applying the results of self-report measures to
individual patients: an example using the Roland-Morris Questionnaire.
The Journal of orthopaedic and sports physical therapy. Apr
1999;29(4):232-239.

6.

Stratford PW, Riddle DL. When minimal detectable change exceeds a
diagnostic test-based threshold change value for an outcome measure:
resolving the conflict. Physical therapy. Oct 2012;92(10):1338-1347.

7.

Albano AD. Reviewing Classical Test Theory. Introduction to Educational
and Psychological Measurement Course Notes: University of NebraskaLincoln; 2016.

139
8.

Linacre JM. Standard Errors and Reliabilities: Rasch and Raw Score.
Rasch Measurement Transactions. 2007;20(4).

9.

Kozlowski AJ, Cella D, Nitsch KP, Heinemann AWDoPM, Rehabilitation
FSoMNUCIL. Evaluating Individual Change With the Quality of Life in
Neurological Disorders (Neuro-QoL) Short Forms. Archives of physical
medicine and rehabilitation. 2016;97(4):650-654.

10.

Bond TG, Fox CM. Applying the Rasch Model: Fundamental
Measurement in the Human Sciences. 3rd ed. New York and London:
Routledge; 2015.

11.

Seamon BA, Kautz SA, Velozo CA. Rasch Analysis of the ActivitiesSpecific Balance Confidence Scale in Individuals Poststroke. Archives of
Rehabilitation Research and Clinical Translation. 2019/12/01/
2019;1(3):100028.

12.

Duncan PW, Sullivan KJ, Behrman AL, et al. Protocol for the Locomotor
Experience Applied Post-stroke (LEAPS) trial: a randomized controlled
trial. BMC neurology. Nov 8 2007;7:39.

13.

Arnadottir SA, Lundin-Olsson L, Gunnarsdottir ED, Fisher AG. Application
of Rasch analysis to examine psychometric aspects of the activitiesspecific balance confidence scale when used in a new cultural context.
Archives of physical medicine and rehabilitation. Jan 2010;91(1):156-163.

14.

Franchignoni F, Giordano A, Ronconi G, Rabini A, Ferriero G. Rasch
validation of the Activities-specific Balance Confidence Scale and its short

140
versions in patients with Parkinson's disease. Journal of rehabilitation
medicine. Jun 2014;46(6):532-539.
15.

Sakakibara BM, Miller WC, Backman CL. Rasch analyses of the Activitiesspecific Balance Confidence Scale with individuals 50 years and older with
lower-limb amputations. Archives of physical medicine and rehabilitation.
Aug 2011;92(8):1257-1263.

16.

Wang YC, Sindhu B, Lehman L, Li X, Yen SC, Kapellusch J. Rasch
Analysis of the Activities-Specific Balance Confidence Scale in Older
Adults Seeking Outpatient Rehabilitation Services. The Journal of
orthopaedic and sports physical therapy. Jul 2018;48(7):574-583.

17.

Linacre JM. A user’s guide to Winsteps Rasch-model computer programs.
Help for Winsteps Rasch Measurement and Rasch Analysis
Software2009: http://www.winsteps.com/a/winsteps.pdf. Accessed 2019.

18.

Wyrwich KW. Minimal important difference thresholds and the standard
error of measurement: is there a connection? Journal of
biopharmaceutical statistics. Feb 2004;14(1):97-110.

19.

Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of
the Roland-Morris Back Pain Questionnaire: part 1. Physical therapy. Nov
1998;78(11):1186-1196.

20.

Botner EM, Miller WC, Eng JJ. Measurement properties of the Activitiesspecific Balance Confidence Scale among individuals with stroke.
Disability and rehabilitation. Feb 18 2005;27(4):156-163.

141
21.

Salbach NM, Mayo NE, Robichaud-Ekstrand S, Hanley JA, Richards CL,
Wood-Dauphinee S. Balance self-efficacy and its relevance to physical
function and perceived health status after stroke. Archives of physical
medicine and rehabilitation. Mar 2006;87(3):364-370.

22.

van de Graaf VA, Noorduyn JCA, Willigenburg NW, et al. Effect of Early
Surgery vs Physical Therapy on Knee Function Among Patients With
Nonobstructive Meniscal Tears: The ESCAPE Randomized Clinical Trial.
Jama. 2018;320(13):1328-1337.

23.

Froud R, Eldridge S, Lall R, Underwood M. Estimating the number needed
to treat from continuous outcomes in randomised controlled trials:
methodological challenges and worked example using data from the UK
Back Pain Exercise and Manipulation (BEAM) trial. BMC Medical
Research Methodology. 2009/06/11 2009;9(1):35.

24.

Malec JF, Ketchum JM. A Standard Method for Determining the Minimal
Clinically Important Difference for Rehabilitation Measures. Archives of
physical medicine and rehabilitation. 2020/06/01/ 2020;101(6):1090-1094.

25.

Collins JP. Measures of Clinical Meaningfulness and Important
Differences. Physical therapy. 2019;99(11):1574-1579.

26.

Caronni A, Picardi M, Gilardone G, Corbo M. The McNemar Change Index
worked better than the Minimal Detectable Change in demonstrating the
change at a single subject level. Journal of clinical epidemiology.
2021/03/01/ 2021;131:79-88.

142
27.

Stevens SS. On the theory of scales of measurement. Science (New York,
N.Y.). Jun 7 1946;103(2684):677-680.

28.

Kahler E, Rogausch A, Brunner E, Himmel W. A parametric analysis of
ordinal quality-of-life data can lead to erroneous results. Journal of clinical
epidemiology. May 2008;61(5):475-480.

29.

Anselmi P, Vidotto G, Bettinardi O, Bertolotti G. Measurement of change
in health status with Rasch models. Health and quality of life outcomes.
Feb 7 2015;13:16.

143
Figure 1. cMDC95 and MDC95 thresholds for the ABC scale

Each line contains all possible cMDC95 thresholds associated with a fixed initial
score. The dash line represents the MDC95 threshold. The dash line representing
the MDC95 threshold is fixed because it is not dependent on a specific initial and
final measure combination. The x-axis represents the patient’s final measure
value, and the y-axis reflects the minimal detectable change threshold value
associated with the combination of initial and final measures. A specific cMDC95
threshold can be identified selecting a final measure value and drawing a vertical
line from the measure’s location on the x-axis to a line that represents a fixed
initial measure of interest. The corresponding y-axis value where the lines
intersect is the cMDC95 threshold for that measure pairing. The different heights
of the curves are related to the amount of standard error associated with the
fixed initial score. For example, the higher a line is on the plot, the closer the
initial measure is to an extreme end of the scale and the lower a line is on the
plot the closer the initial measure is to the middle of the scale.
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Figure 2. Comparing cMDC95 and MDC95 thresholds with Patient Examples
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Figure 2 presents three theoretical patient examples to demonstrate how
misclassification of change occurs when using the MDC95 compared to a
cMDC95. The x-axis represents the change scores based on the person’s initial
measure value on the ABC. The y-axis represents the change scores required for
detectable change. The blue dash line represents the cMDC95 curve associated
with the initial measure value for the theoretical patient and the black dash line
represents the MDC95. The change threshold can be identified by drawing a
vertical line from the x-axis of the patient’s change score to where it intersects
with the blue dash line. The associated y-value with the intersection is the
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required threshold for detectable change. The change score magnitude can be
compared to the threshold to see if the patient has a detectable change. These
figures compare whether the patient had detectable change under the cMDC95
and MDC95 approach. The Misclassification Zone is noting the range of scores
where the cMDC95 and MDC95 approach do not agree. In A and B the cMDC95
identified a change but the MDC95 did not in the Misclassification Zone. In C the
cMDC95 did not identify change and the MDC95 did in the Misclassification Zone.
Outside of the Misclassification Zone the cMDC95 and MDC95 were in agreement.
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Associations between biomechanical variables of walking performance
and muscle coordination during self-selected steady-state walking
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Abstract
Background
Factorization of EMG data into modules has been used to quantify muscle
coordination during gait. However, no one has examined the association
between modules and observable biomechanical variables during walking
outside of computer simulation models.

Research Question
Are modules associated with observable measures of biomechanical functions
during steady-state walking?

Methods
We used a cross-sectional design with twenty, healthy individuals who completed
3, 30-second trials of steady-state walking at self-selected speeds on an
instrumented treadmill with motion capture. EMG was collected from 8 lower
extremity muscles bilaterally. Non-negative matrix factorization was used to
extract 4 modules. Changes in biomechanical variables were quantified using the
area under the curve for each bin of the gait cycle per step. Variables included
anterior-posterior and vertical ground reaction force, leg angle, and leg length.
Generalized mixed linear models with random coefficients for person by leg and
person by step interactions were used to quantify the association between
changes in module activation with biomechanical measures of walking.
Comparisons within bins between modules and biomechanical variables were

151

selected a priori based on hypothesized relationships suggested from previous
computer simulation work. Bonferroni corrections were applied for evaluating
statistical significance.

Results
We found significant positive associations between Module 1 and vertical ground
reaction force during early stance; Module 2 and AP and vertical ground reaction
forces during late stance; Module 3 and changes in leg angle and leg length
during swing phase, and decreased AP ground reaction forces in early stance;
Module 4 and increased vertical ground reaction force in early stance, and
decreased leg angle in late swing phase.

Significance
Our findings demonstrate that there are physiologically expected associations
between biomechanical variables and modules during steady-state walking.
Results from this study can be used for comparisons with pathological conditions
impacting walking performance and informing biomarkers of walking recovery.

Keywords: Gait, biomechanics, electromyography, coordination, modules
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Introduction
Walking is a particularly complex task that requires a high degree of wellcoordinated muscle activity.[1] Recently, growing evidence has supported that
the complex coordination of muscle activity during walking can be quantified
using a module-based analysis.[2-5] Module-based analyses apply factorization
algorithms to surface electromyographic (EMG) data collected from multiple
muscles to identify modules that contain co-excited muscles with their activation
profile during the gait cycle. Four modules are typically identified in healthy
walking that have robust consistency in composition and timing of activation
during the gait cycle across healthy individuals.[2, 4] Module 1, active in early
stance, primarily contains activity from gluteus medius, rectus femoris, and
vastus medialis. Module 2, active in late stance, consists of soleus and medial
gastrocnemius activity. Module 3, active in early stance and swing, consists of
tibialis anterior and rectus femoris. Module 4, active in late stance and early
swing, consists of medial and lateral hamstring activity. However, factorization
algorithms used to generate modules, are primarily a means of data reduction
and may not necessarily produce factors, or modules, that are physiologically
relevant.[6]
Neptune and colleagues[6] addressed this concern using a muscleactuated forward dynamic computer simulation model with module data from
Clark et. al..[2] They were able to show that the typical 4 modules were sufficient
for producing coordinated waking. Additionally, they identified the contributions of
each module to key biomechanical functions during walking. Module 1 provided
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body support and deceleration during early stance, Module 2 provided body
support and forward propulsion in late stance, while Module 3 and 4 provided leg
acceleration in early swing and deceleration in late swing to prepare for foot
contact.
No one to date has demonstrated the association between observable
walking biomechanics and modules during healthy walking, outside of simulation.
Therefore, while simulation has shown the biomechanical functions the modules
should perform, no one has yet linked module performance with quantified
biomechanical performance during walking. The purpose of this study was to
quantify the associations between modules and biomechanical variables of
walking that reflect the functions described in Neptune et al., 2009 during steady
state walking at self-selected speeds in healthy adults. Specifically, we compared
the association between module activation with changes in anterior-posterior
(i.e., propulsion) and vertical (i.e., body support) ground reaction forces, leg
angle (i.e. stance to swing transition), and length (i.e., leg clearance).
Specifically, we hypothesized that Module 1 would be associated with changes in
anterior-posterior and vertical ground reaction forces during early stance; Module
2 would be associated with changes in anterior-posterior and vertical ground
reaction forces, and trailing leg angle during late stance; Module 3 would be
associated with changes in anterior-posterior ground reaction forces during late
stance, and leg angle and leg length during swing phase; and Module 4 would be
associated with changes in anterior-posterior and vertical ground reaction forces
during early stance, and leg angle in late swing phase.
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Methods
Participants:
Participants for this study included 20 healthy older adults between the
ages of 40-85. Participants were excluded if they had any neurologic disease or
significant orthopedic impairments in the lower limb that would limit walking
performance. All participants signed a written informed consent form approved by
the Institutional Review Board at the Medical University of South Carolina and
conformed to the Declaration of Helsinki.

Procedures:
Participants completed three, 30 second, walking trials at self-selected
walking speed on a split belt instrumented treadmill (Bertec; Columbus, OH).
Ground reaction forces were sampled at 2000 Hz. Force data was then filtered
with a 4th order Savitzky-Golay filter and resampled at 100 Hz. Whole-body 3D
kinematic data was recorded by a 16-camera motion capture system
(PhaseSpace, Inc.; San Leandro, CA) and sampled at 120 Hz, filtered with a 4th
order Savitzky-Golay filter, and resampled at 100 Hz. Bipolar pre-amplified
electrodes (Motion Lab Systems; Baton Rouge, LN, USA) were used to collect
surface EMG from eight muscles bilaterally: tibialis anterior, soleus, medial
gastrocnemius, vastus medialis, rectus femoris, medial hamstrings, lateral
hamstrings, and gluteus medius. Surface EMG was sampled at 2000 Hz, highpass filtered at 40 Hz, demeaned, rectified, and low-pass filtered at 4 Hz using a
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zero-lag forth order Butterworth filter and resampled to 100 Hz. EMG amplitude
for each muscle was averaged within each region of the gait cycle (or bin): (1)
initial contact/loading response (initial double support), (2) first half of single-leg
stance, (3) second half of single-leg stance (4) second double support, (5) first
half of swing, (6) second half of swing) for each step. The bin with the highest
average was used to normalize EMG amplitude across all trials for an individual.
Data for each step was time normalized to the gait cycle (0-100%)

Data Analysis:
NON-NEGATIVE MATRIX FACTORIZATION (NNMF): Quantifying muscle
coordination was done using a module analysis with NMMF. EMG from each
muscle for per leg was combined into an m x t matrix (EMGO), where m is the
number of muscles (8) and t is the time base (t = number of gait cycles x 101).
An NNMF algorithm is applied to the m x t matrix for each person. NNMF creates
two matrices that define a pre-selected number of modules (n), in this case n = 4.
One is an m x n matrix indicating the relative weighting of each muscle within
each module, also known as the W matrix. The second is an n x t matrix
indicating the activation timing profile of each module for each step in the trial,
also known at the H matrix. NNMF assumes that the muscle weightings are fixed
across all steps and allows for muscles to be belong to more than one module.
NNMF runs an iterative optimization procedure to minimize the error by adjusting
the muscle weightings (W matrix) and activation profiles (H matrix). The H matrix
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for each module per person was divided into separate steps and an area under
the curve was calculated for each bin of the gait cycle per step.

BIOMECHANICAL VARIABLES FOR WALKING: Biomechanical variables were
quantified from force and motion capture data using custom software in MATLAB
(Mathworks, Natick, MA). Specific kinematic and kinetic variables of interest were
selected to represent the biomechanical subtasks of walking. These variables
included:

(1) Changes in ground reaction force or impulse (the time integral of the ground
reaction force) in the anterior-posterior (AP), and vertical directions. Impulse was
calculated by taking the net area under the curve (AUC) for each component
(AP, vertical) of the ground reaction force in each bin of the gait cycle.

(2) Changes in leg angle in the anterior-posterior direction. Leg angle was
calculated by taking the angle from a vertical line between the ground and center
of mass of the pelvis and a line between the center of mass of the pelvis to the
center of mass of the foot. The changes in leg angle were represented by the net
AUC in each bin for each step.

(3) Changes in leg length. Leg length was calculated as the distance from the
center of mass of the pelvis to the center of mass of the foot. We normalized leg
length to for each participant to the distance between their pelvis center of mass
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and foot center of mass during static standing. Changes in leg length were
represented by the AUC in each bin for each step.

Statistical Analysis:
All statistical analyses were completed in SAS version 9.4 (SAS Inc.,
Cary, NC). PROC GLIMMIX was used to fit linear mixed models with random
coefficients. The participant variable, participant by leg (i.e., right and left)
interaction, and participant by step interaction were included as random effects in
the model. The random coefficients model allowed us to examine the association
between module and biomechanical variables while controlling for variability at
the individual and group levels. Magnitude of association was quantified using
parameter estimates. We used a Bonferroni correction for the number of tests
(tests = 18) resulting in an alpha level of 0.003.

Results
Our sample consisted of 20 healthy adults with a mean age of 58 years.
Twelve individuals were female, 17 were Caucasian, and 3 Black. Demographic
data is presented in Table 1.

(INSERT TABLE 1 HERE)

Module Weighting and Activation Profiles
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Module weighting and activation profiles are presented in Figure 1. The
four modules’ weightings were like previously published muscle compositions
and displayed similar timing curves, with the exception of increased rectus
femoris activity in Module 1 compared to Module 3.[2, 6] Visually, there was
consistency across participants and between legs for module weightings and
activation profiles. Module 1 was primarily active in early stance and consisted
mainly of muscle activity from the gluteus medius, rectus femoris, and vastus
medialis. Module 2 was primarily active in late stance and consisted mainly of
muscle activity from the medial gastrocnemius and soleus. Module 3 was
primarily active in swing phase and early stance, consisting mainly of muscle
activity from the tibialis anterior and rectus femoris. Module 4 was primarily active
in late swing phase and early stance, consisting mainly of muscle activity from
the medial and lateral hamstrings. Module weighting and activation profiles are
presented in Figure 1.

(INSERT FIGURE 1 HERE)

Module Associations with Biomechanical Variables
Average curves for each biomechanical variable during the gait cycle are
presented in Figure 2. Each plot contains the group mean (black line), 1 (light
gray) and 2 (dark gray) standard deviation ranges. Individual averages across
steps for each leg (right and left) are shown as gray curves. Descriptive statistics
for each biomechanical variable mean AUC and standard deviation are
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presented by bin in Table 3. All parameter estimates and p-values from the linear
mixed models are presented in Table 4 by module.

(INSERT FIGURE 2 HERE)
(INSERT TABLE 2 HERE)

MODULE 1: Module 1 was found to have a positive association with increases in
vertical ground reaction forces in bin 1 (parameter estimate (PE)=68.38 standard
error (6.05); p<0.0001) and bin 2 (PE=39.56 (7.66); p<0.0001). Module 1 also
had a positive association with increases in AP ground reaction force in bin 2
(PE=5.49 (1.54); p<0.0001) and no significant association with bin 1.

MODULE 2: Module 2 was found to have a positive association with cumulative
increases in vertical and AP ground reaction forces across bins 3 and 4, with the
greatest magnitude in bin 4 (Vertical – PE=286.39 (8.12), p<0.0001; AP –
PE=38.17 (1.48), p<0.0001). Additionally, Module 2 was associated with
cumulative increased leg extension (i.e., increased negative AUC for leg angle)
across bins 3 (PE=-2.35 (0.16); p<0.0001) and 4 (PE=-8.43 ()0.32); p<0.0001).

MODULE 3: Module 3 was associated with decreases in AP ground reaction
force in bin 1 4 (PE=-6.0 (1.44); p<0.0001); a decrease in leg angle, or leg
extension, in bin 5 (PE=-1.45 (0.28); p<0.0001); and an increase in leg length in

160

bin 6 (PE=0.03 (0.01); p<0.0017). Module 3 did not have any significant
associations with AP leg angle in Bin 6 or leg length in Bin 5.

MODULE 4: Module 4 was positively associated with increases in vertical ground
reaction force during bin 1 (PE=37.48 (4.43); p<0.0001) and with decreases in
leg angle during bin 6 (PE=-2.46 (0.39); p<0.0001). We did not find any
significant associations between Module 4 and AP ground reaction force in bin 1.

(INSERT TABLE 3 HERE)

Discussion
Our results demonstrate that there is a strong association with modular
organization of muscle coordination and biomechanical variables of walking
performance at self-selected speeds. We found several associations that
supported our proposed hypotheses which were informed by previous computer
simulation work[6] and are consistent with the theory that neural organization
drives biomechanical output during movement.[3, 4, 6-10] The 4 modules we
identified for each individual were consistent across participants and previous
analyses using similar methodology, with the exception of increased rectus
femoris activity in Module 1.[2, 11]
We hypothesized that Module 1 would be associated with changes in AP
and vertical ground reaction forces in bins 1 and 2 because simulation showed
Module 1 contributed to body support and braking during early stance phase.[2,
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6] We observed that Module 1 was primarily associated with increases in vertical
ground reaction force in bins 1 and 2. This association is supported by the
primary contributions of vastus medialis and rectus femoris in Module 1. Several
simulations studies have shown that vastus medialis contributes to body support
through vertical ground reaction force[6, 12-14] and that rectus femoris
contributes to body support with vastus medialis when co-active in early
stance.[14, 15] However, contrary to our hypothesis, we did not see an
association with AP ground reaction forces during bin 1 where one may expect to
see a negative AP impulse (i.e., braking or backward propulsion) to correspond
with deceleration and vastus medialis activity. [6, 12-14] Our observation of a
positive association with increase AP ground reaction force in bin 2 could
potentially be explained by gluteus medius activity since this muscle can
contribute to forward propulsion, in addition to body support, during early
stance.[12, 13]
We hypothesized Module 2 would be associated with changes in AP and
vertical ground reaction forces in bins 3 and 4 because Module 2 has been
shown to contribute to body support and forward propulsion during stance phase
in simulation.[2, 6] Additionally, we hypothesized that Module 2 would be
associated with increased leg extension which has been associated with
propulsion in terminal stance during walking.[16, 17] Consistent with our
hypotheses, we observed that Module 2 was primarily associated with a positive
increase in vertical and anterior-posterior ground reaction forces across bins 3
and 4. We also observed that Module 2 was also strongly associated with leg
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angle movements into extension across mid to late stance, bins 3 and 4. These
findings are consistent with previous studies linking trailing leg angle and forward
propulsion. [16, 17] Our findings suggest that muscle activity is coordinated to
place the foot in an optimal position to maximize propulsion forces with respect to
vertical forces generated by the ankle plantarflexors. We also found that Module
2 was associated with an increase in foot velocity during early swing in the
anterior-posterior direction.
We hypothesized that Module 3 would be associated with changes in leg
angle and leg length during swing phase because it is thought to coordinate with
Module 4 to accomplish swing phase.[2, 6] We found that Module 3 was
associated with leg angle (increased extension) in bin 5 and increases in leg
length in bin 6, but we did not find any significant association for leg angle in bin
6 or leg length in bin 5, partially proving our hypothesis. We also hypothesized
that Module 3 would be associated with decreases in AP ground reaction force
(i.e., propulsion) during bin 4. We confirmed this hypothesis which supports
previous findings that increased tibialis anterior activity in late stance can
counteract propulsion by the ankle plantarflexors.[18]
Lastly, we hypothesized that Module 4 would be associated with leg angle
in late swing phase (capturing leg deceleration) and increases in AP and vertical
ground reaction forces during early stance.[2, 6] Our findings partially confirmed
our hypotheses because we observed associations between Module 4 and leg
angle in late swing and with vertical ground reaction forces in early stance. The
negative association we saw in late swing with leg angle would suggest that
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Module 4 is contributing to a decrease in leading limb angle in preparation for
heel strike and stance phase.

Limitations
There are several limitations to this study. We selected biomechanical
variables based on theorized linkages between the biomechanical functions of
body support, propulsion, and leg swing. Our results suggest that there may have
been other variables with stronger associations to these biomechanical functions,
especially with respect to leg swing and propulsion; for example, using pelvic and
foot center of mass acceleration to capture changes in velocity at the trunk and
leg segments. Another limitation was our constraint to the sagittal plane of
movement. Future studies should examine associations of modules with key
biomechanical variables in the frontal plane.[6] Also, we constrained our
quantification of biomechanical variables to the net area under the curve for each
bin. It is reasonable to consider exploring associations with positive and negative
AUCs especially for variables that may have primarily negative or positive values
during a single bin. Additionally, our large sample size left us overpowered.
Although generalized mixed linear models are very robust[19] and able to control
for repeated measures (i.e., between legs and steps), we were at risk for
identifying significant findings that were not meaningful[20]. We took steps to
address this, including hypothesizing associations a priori and applying a more
conservative correction for the number of statistical tests. Lastly, our study
design is not able to prove causation between modular activation and changes in

164

biomechanical variables, although the simulation work has shown that the
changes are consistent with module contributions to the dynamics of walking.
Prospective study designs are needed to confirm our findings are causal.

Future Directions
Our findings provided more evidence to strengthen the theory that
modules share a mechanistic link with observable biomechanical variables that
are measurable during walking. This seems to suggest that modules may have a
biomechanical signature that is expressed which could potentially be used as a
biomarker for walking-specific motor control recovery in persons with pathological
gait. Future studies should examine whether observed changes in module
activity have similar associations with changes in biomechanical variables in
pathological walking. This would be especially helpful for individuals with stroke
where modules may reflect the loss of movement fractionation common in this
patient population[2, 21-29] and can change with interventions.[11, 21, 30, 31] A
biomechanical biomarker for modules could enable clinicians to have a surrogate
measure for the measurement of muscle coordination during walking and inform
patient specific interventions.[32]
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Table 1. Participant Demographics
n = 20
Age (years)

58.2 (10.1) [40-79]

Sex
Male

8 (40%)

Female

12 (60%)

Race
White

17 (85%)

Back

3 (15%)

Continuous variables are presented as mean (standard deviation) [range]
Categorical variables are presented as count (frequency - percentage)
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Figure 1. Muscle weightings and activation profiles for each module
Activation Profiles

Module 4

Module 3

Module 2

Module 1

Muscle Weightings

Muscle weighting plots show the strength of representation for each muscle
within a module. Gray bars are used to show the muscle weightings for each leg
per participant per module. The black bar represents the group mean. Activation
profiles represent the activation of the module over the gait cycle. Thin gray lines
represent the profiles for each leg per participant averaged across all steps. The
black line represents the group mean. Solid vertical lines represent the group
mean for the start and stop of each bin. Dash vertical lines are presented to the
right and left of the mean to show the range of values observed from our sample
(i.e., average per person per leg) for the start and stop of each bin.
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TA – tibialis anterior; SO – soleus; MG – medial gastroc; VM – vastus medialis;
RF – rectus femoris; LH – lateral hamstring; MH – medial hamstring; GM –
gluteus medius
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Figure 2. Average curves for biomechanical variables of interest across the gait
cycle

Biomechanical plots show the change for a variable across the gait cycle. Gray
lines represent the average curve for each leg per participant. The black line
represents the group mean. A dark shaded region surrounding the black line
represents 1 standard of deviation and lighter shaded region represents 2
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standards of deviation. Solid vertical lines represent the group mean for the start
and stop of each bin. Dash vertical lines are presented to the right and left of the
mean to show the range of values observed from our sample (i.e., average per
person per leg) for the start and stop of each bin.
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Table 2. Descriptive Statistics for Biomechanical Variable Areas Under the Curve
Bin 1

Bin 2

Bin 3

Bin 4

Bin 5

Bin 6

AP Ground
Reaction
Force

-9.66
(3.26)

-9.42
(3.98)

5.77
(3.31)

13.21
(3.75)

.

.

Vertical
Ground
Reaction
Force

94.18
(34.06)

158.02 157.60
(31.08) (31.96)

96.95
(28.81)

.

.

AP Leg Angle

3.44
(0.78)

1.31
(0.48)

-0.80
(0.58)

-2.97
(0.69)

-2.78
(0.91)

2.45
(0.91)

Leg Length

0.19
(0.05)

0.19
(0.02)

0.19
(0.02)

0.18
(0.04)

0.17
(0.02)

0.18
(0.02)

Values are presented as mean (standard deviation)
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Table 3. Associations between Biomechanical Variables and Modules
A. Module 1

AP Ground Reaction Force
Vertical Ground Reaction
Force

Bin 1

Bin 2

1.68 (0.81)
p=0.039
68.38 (6.05)
p<0.0001*

5.49 (1.54)
p<0.0001*
39.56 (7.66)
p<0.0001*

B. Module 2

AP Ground Reaction Force
Vertical Ground Reaction
Force
AP Leg Angle

Bin 3

Bin 4

16.11 (1.13)
p<0.0001*
223.97 (6.96)
p<0.0001*
-2.35 (0.16)
p<0.0001*

38.17 (1.48)
p<0.0001*
286.39 (8.12)
p<0.0001*
-8.43 (0.32)
p<0.0001*

C. Module 3
Bin 4

Bin 5

Bin 6

AP Ground Reaction
Force
AP Leg Angle

-6.0 (1.44)
p<0.0001*
.

.

.

-1.45 (0.28)
p<0.0001*

0.73 (0.38)
p=0.053

Leg Length

.

0.01 (0.01)
p=0.52

0.03 (0.01)
p=0.0017*

D. Module 4

AP Ground Reaction Force
Vertical Ground Reaction
Force
AP Leg Angle

Bin 1

Bin 6

0.95 (0.59)
p=0.106
37.48 (4.43)
p<0.0001*
.

.

Values presented are parameter estimates with p-values

.
-2.46 (0.39)
p<0.0001*
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* indicates significant finding, p<0.003
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performance in individuals post-stroke: a preliminary study
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Abstract:
Background:
Transcranial direct current stimulation (tDCS) has mixed effects on walking
performance in individuals post-stroke. This is likely the result of variations in
tDCS electrode montages and individualized responses. The purpose of this
study was to quantify the effects of a single session of tDCS using various
electrode montages on post-stroke walking performance.

Methods:
Individuals with chronic stroke (n=16) participated in a double-blind, randomized
cross-over study with sham stimulation and three tDCS electrode montages. Gait
speed, paretic step ratio and paretic propulsion were assessed pre- and poststimulation at self-selected and fastest comfortable speeds. Changes in muscle
activation patterns with self-selected walking were quantified by the number of
modules derived from non-negative matrix factorization of EMG signals for
hypothesis generation.

Results:
There was no significant effect of active stimulation montages compared to
sham. Comparisons between each participant’s best response to tDCS and
sham show personalized tDCS may have a positive effect on fastest comfortable
overground gait speed (p=0.084), paretic step ratio (p=0.095) and paretic
propulsion (p=0.090), and self-selected paretic step ratio (p=0.012). Participants
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with 2 or 3 modules at baseline increased module number in response to the all
experimental montages and sham, but responses were highly variable.

Conclusions:
A single session of tDCS may affect clinical and biomechanical walking
performance, but effects appear to be dependent on individual response
variability to different electrode montages. Our findings are consistent with
responses to various tDCS electrode montages being the result of underlying
neuropathology and we recommend examining how individual factors affect
responses to tDCS.

Key Words: (6 allowed)
Brain stimulation, electromyography, stroke, walking, biomechanics, rehabilitation
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Individuals post-stroke commonly report impaired walking performance
that is associated with the severity of central nervous system damage.(1)
Transcranial direct current stimulation (tDCS) holds promise as a potential
therapeutic adjuvant capable of modifying or modulating the central nervous
system and may be able to augment standard rehabilitation strategies for
recovery of walking function.(2, 3) tDCS is a non-invasive brain stimulation
technique that uses a small electrical current to modulate cortical activity and is
simple to administer, low-cost, and low-risk.(4, 5) tDCS neuromodulation has
been shown to up or down regulate cortical excitability and effect
interhemispheric imbalances that can result from a stroke(6, 7) including deeper
structures like the leg area of the motor cortex in healthy individuals(2, 8, 9) and
persons post-stroke.(3) Regulating cortical excitability or interhemispheric
imbalance has been hypothesized as a mechanism for improving motor
function(6, 10) (primarily in the upper extremity(7, 11-13)) and aphasia(14, 15).
Treating interhemispheric imbalance may have a larger influence on walking
performance given the bilateral task requires coordination between
hemispheres(16) although this model has not been conclusively translated to the
lower extremity.
Despite the promise of tDCS acting on impaired cortical activity to improve
motor function the effects are often small bringing into question the therapeutic
utility of tDCS in clinical practice especially for walking rehabilitation (i.e. gait
speed and endurance).(16-18) One hypothesized reason for this is the limited
evidence to guide personalization of tDCS prescription to combat the inherent
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heterogeneity of the pathology.(18) Few experiments examine the effect of
varying available parameters such as; treatment frequency, duration and length,
current strength, and electrode montage.(14, 17-19)
Electrode montage is of specific therapeutic interest in post-stroke
rehabilitation for walking because electrode placement informed by
neuroanatomical and physiological pathology has had a positive effect on clinical
measures of upper extremity and hand function.(7, 11-13) Improvements are
seen with either excitatory (anode applied over ipsilesional M1)(7) or inhibitory
stimulation (cathode is applied over contralesional M1)(11) when compared to
sham.(12, 13) Studies examining the effects of dual montages (anode over
ipsilesional M1 and cathode over contralesional M1 simultaneously) had positive
findings on measures of walking function (decreased Timed Up and Go
times(20), increased 6-minute walk test distance(21), and increased paretic
power(22)) in response to a single session of tDCS. Yet, it remains unknown how
dual montages compare to single anode or cathode configurations against sham
stimulation on walking performance.(17)
The purpose of this study was to quantify the effects of a single treatment
of tDCS delivered during treadmill walking on gait speed, paretic step ratio and
paretic propulsion in individuals post-stroke and to compare three electrode
montages to sham stimulation: 1.) Excitatory (anode over ipsilesional M1), 2.)
Inhibitory (cathode over contralesional M1, and 3.) Dual (an anode over
ipsilesional M1, and a cathode over contralesional M1). We hypothesized the
dual electrode montage would have the largest effect on measures of walking
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performance as walking is a bilateral, coordinated activity resulting from restored
interhemispheric balance. In an exploratory analysis, we examined the effect of
tDCS stimulation and electrode montage on muscle activation patterns in
individuals post-stroke during treadmill walking.

Materials and Methods:
Participants: Eighteen individuals with chronic stroke were enrolled and sixteen
completed all study procedures. One participant dropped-out and one did not
meet the inclusion criteria. Demographic data are presented in Table 1.

(INSERT TABLE 1 HERE)

Inclusion criteria were: 1) age 18 to 85 years old; 2) at least six-months poststroke; 3) residual lower extremity paresis (Fugl-Meyer Lower Extremity motor
score <34); 4) ability to walk independently at least 10 feet; 5) self-selected 10meter gait speed < 0.8 m/s (at time of consent); and 6) provision of informed
consent. Participants were excluded for: 1) significant musculoskeletal problems
limiting hip and knee extension or ankle plantarflexion to neutral joint positions; 2)
self-reported history of unstable cardiovascular disease or severe osteoporosis,
or 3) pregnancy. Screening, testing and tDCS interventions were completed by a
team of licensed physical therapists and associated study staff. All participants
signed a written informed consent form approved by the Institutional Review
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Board at the Medical University of South Carolina and conformed to the
Declaration of Helsinki.

Experimental Procedure: We used a double-blind, randomized, cross-over
experimental design. A timeline of procedures is presented in Figure 1.
Participants were screened and completed a clinical assessment, which included
the lower extremity motor portion of the Fugl-Meyer(23), Berg Balance Test(24),
and Dynamic Gait Index(25). Participants then completed three single sessions
of tDCS and one sham stimulation session. Sessions were blocked randomized
to control for order effects and separated by a minimum 48-hour washout period.
Participants completed pre- and post-stimulation testing for each session.

(INSERT FIGURE 1 HERE)

Transcranial direct current stimulation: tDCS was delivered using an EMPI unit
(Chattanooga; Hixson, TN) and 1.75 cm2 sponges prepped with 0.9% saline
solution. This created a current density of 0.1 mA/cm2 consistent with
recommendations.(26) We informed participants they may feel a slight tingling
sensation that should subside within approximately 60 seconds. Stimulation was
ramped up to 2mA x at a dose rate of 40mA/min for a total of 20 minutes.
Experimental conditions administered tDCS with one of the following electrode
montages illustrated in Figure 2: 1) excitatory (anode over target ipsilesional leg
M1 area), 2) inhibitory (cathode over target contralesional leg M1 area) or 3) dual
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(both excitatory and inhibitory montages applied simultaneously to target both leg
M1 areas). Reference pads for the excitatory and inhibitory montages were
placed on the ipsilateral shoulder. Modeling work has shown that this type of
extracephalic pad placement creates a more focal concentration of current under
the electrode, increasing penetration depth.(27) Studies with healthy individuals
suggest that extracephalic pad placement has a greater effect on cortical
excitability (9) and neuromotor output (28) compared to cephalic placement for
deeper M1 areas of the leg. The dual montage used two EMPI units to deliver
simultaneous active anodal stimulation over ipsilesional M1 and cathodal
stimulation over contralesional M1. Reference pads for both units were placed on
the respective ipsilateral shoulder. In each montage, M1 location was determined
in a forward seated position approximately 1cm lateral to the vertex and 1cm
posterior to a hypothetical line between the tragi creating a 2cm gap between the
cephalic pads in the dual montage configuration.

(INSERT FIGURE 2 HERE)

Stimulation parameters were set prior to each session by an unblinded
investigator and participants were fitted with two EMPI units using pad placement
described in the dual experimental setup to maintain participant and staff blinding
to active stimulation parameters. Sham stimulation was done by turning on the
EMPI units to apply 30 seconds of stimulation before manually turning the units
off by an unblinded investigator (per published guidelines).(29) Participants
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received tDCS or sham stimulation for 5 minutes in a seated position and then
continued receiving stimulation while walking for 15-minutes on a treadmill.
Participants walked at their fastest comfortable speed on the treadmill to provide
an adequate training stimulus. Faster walking speeds are commonly used in
rehabilitation programs having been shown to have immediate and long-term
effects on walking performance for persons post-stroke.(30, 31) Walking was
paused every 5-minutes to assess cardiovascular response to exercise (i.e.
blood pressure, heart rate, and activity tolerance). Walking immediately resumed
unless continuation was contraindicated for safety. A ceiling harness system
without body-weight support was used to prevent falls or injury. Verbal cues to
alter gait pattern were not provided. Minimal physical assistance was provided to
prevent tripping or interruptions in walking and not given during data collection
trials.

Data analysis: GaitRite (CIR Systems, Inc.; Franklin, NJ) data was used to
calculate self-selected and fastest comfortable overground gait speeds.
Participants walked over a 24-foot GaitRite for one trial at their self-selected
speed and three trials at their fastest comfortable speed during pre- and posttesting. Participants also walked for three, 30-second trials on a split belt
instrumented treadmill (Bertec; Columbus, OH) at self-selected and fastest
comfortable speeds, which did not have to match overground speeds. Ground
reaction force (GRF) data was sampled at 1000 Hz to derive paretic step ratio
and paretic propulsion using methods previously described by our lab.(32)
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Paretic propulsion was calculated by dividing the positive anterior impulse of the
paretic leg by the anterior impulse of both legs combined.(32) Paretic step ratio
was calculated from the percentage of stride length performed by the paretic
step.(33) Paretic step ratio and paretic propulsion were expressed as the
absolute value of deviation from symmetry (0.5).
Muscle coordination patterns were quantified for each participant during
self-selected treadmill walking by extracting modules using a non-negative matrix
factorization (NNMF) algorithm.(34, 35) Surface EMG was recorded at 2000 Hz
with bipolar pre-amplified electrodes (Motion Lab Systems; Baton Rouge, LN,
USA) at the following eight muscle locations bilaterally: tibialis anterior, soleus,
medial gastrocnemius, vastus medialis, rectus femoris, medial hamstrings, lateral
hamstrings and gluteus medius.(36) Specific post-processing of EMG signals
and selection of modules for the paretic leg can be found in Clark et. al.,
2010.(37)
Statistical analyses were conducted using SAS version 9.4 (SAS Institute
Inc. Cary, NC) on change scores for gait speed, paretic step ratio and paretic
propulsion at self-selected and fastest comfortable speeds. A one-way ANOVA
(or Kruskal-Wallis Test for non-parametric data) examined the main effect of
active stimulation across all three montages compared to sham for each variable
of walking performance. Post-hoc testing with multiple t-tests (or Wilcoxon RankSum tests) were performed to compare the effects of each electrode montage.
Corrections for multiple comparisons were not performed for this preliminary
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study. Changes in module number are reported observationally to generate
hypotheses for future studies.

Results:
Walking performance: No significant main effect of active stimulation montage
was observed for overground walking speed at self-selected (ANOVA; F=0.44,
p=0.723, df=3) or fastest comfortable speed (Kruskal-Wallis; Χ2=2.419, p=0.490,
df=3). Additionally, no significant effect was found for paretic step ratio at selfselected (Kruskal-Wallis; Χ2=3.013, p=0.389, df=3) or fastest comfortable speeds
(Kruskal-Wallis; Χ2=1.357, p=0.716, df=3) or paretic propulsion at self-selected
(ANOVA; F=0.31, p=0.819, df=3) or fastest comfortable speeds (Kruskal-Wallis;
Χ2=0.749, p=0.862, df=3). Group descriptive statistics for each variable are
presented in Table 2.

(INSERT TABLE 2 HERE)

Visual inspection of the data showed a high degree of overall response variability
to each electrode montage for each measured variable. Table 3 shows each
participant’s best response to an electrode montage for each variable.

(INSERT TABLE 3 HERE)
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To examine the possibility participants may exhibit preferential responses to
specific montages, we compared each participant’s best response to stimulation
with sham for each variable using t-tests (or Wilcoxon Rank-Sum test for nonparametric data). We also accepted a higher false positive rate of 10%
(alpha=0.1) for generating exploratory hypotheses. We observed a significant
difference and improved fastest comfortable overground gait speed (mean
difference=0.06 m/s, 95% CI [-0.008 – 0.12], t-test p=0.084) but not self-selected
(mean difference=0.05, 95% CI [-0.036 – 0.137], t-test p=0.242). There was a
significant effect for improvement in paretic step ratio (median=0.017, IQR
[0.023], Wilcoxon; p=0.012) and paretic propulsion (mean difference=0.035, 95%
CI [-0.006 – 0.077], t-test p=0.090) at self-selected speeds and paretic step ratio
(mean difference=0.01, 95% CI [-0.002 – 0.02], t-test p=0.095) at fastest
comfortable speeds. No differences were found for paretic propulsion
(median=0.002, IQR [0.068], Wilcoxon; p=0.645) at fastest comfortable speeds.

(INSERT TABLE 4 HERE)

Muscle activation patterns: In our sample, 6 participants used 2 modules, 6
participants used 3 modules and 4 participants used 4 modules for self-selected
comfortable treadmill walking at baseline. The change in module number for the
participants in response to tDCS with each electrode montage and sham are
presented in Table 5.
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(INSERT TABLE 5 HERE)

Only one of the 6 participants with 2 modules did not change their module
number after tDCS or sham stimulation. Four of the remaining 5 participants
increased module number with the excitatory, inhibitory and/or dual electrode
montage and 4 of the 6 participants increased module number with sham
stimulation. One 2 module participant increased module number with all
electrode montages and sham stimulation.
One of the 6 participants with 3 modules did not change their module
number after tDCS or sham stimulation. Two participants did not change their
module number in response to any tDCS condition but did to sham stimulation.
One of these individuals improved module number and the other decreased. One
participant increased module number after the inhibitory montage, one in
response to the excitatory montage and dual montage and one in response to
the inhibitory and dual montage. However, all three of these participants also
increased module number in response to sham stimulation.
Although module number cannot increase from 4, we observed two
instances where module number decreased in those with 4 modules at baseline.
One participant reduced module number to 3 in response to the dual montage
and sham stimulation, the other reduced module number to 3 in response to the
inhibitory montage.
A small positive association was found between a change in module
number and change in paretic propulsion symmetry (r=0.29; p=0.0251) across all
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conditions; including sham stimulation. However, this association was not
present within experimental and sham conditions separately. There were no
associations between changes in module number and changes in gait speed,
paretic step ratio or paretic propulsion at self-selected walking speeds when
examining all tDCS conditions or within each experimental montage group.

Discussion:
Our aim was to compare the immediate effects of three tDCS electrode
montages and sham stimulation on post-stroke walking performance. We used a
double blind, placebo controlled, randomized cross-over design to evaluate
changes in gait speed, paretic step ratio and paretic propulsion. We found no
group main effects for any of the electrode montages compared to sham
stimulation on walking performance immediately following one session of tDCS,
which was inconsistent with our hypothesis.
Our lack of a single session effect on post-stroke walking performance is
comparable with findings from other experiments.(20-22) The immediate effect of
tDCS with an excitatory or dual electrode montage has not had a significant
effect on walking performance with the exception of the 6-minute walk and
Timed-up and Go tests, compared to sham.(20-22) The authors hypothesized the
large variation in participant response to tDCS likely caused the negative
findings(20-22) and this heterogeneity continues to be a key challenge in poststroke tDCS neuromodulation research.(18) In an exploratory attempt to address
variation in our sample, we tested the main effect of tDCS by comparing each
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participant’s best response of the electrode montages to sham stimulation. This
is based on the assumption that individuals may respond to different montages
based on unknown characteristics likely arising from the variety of motor network
impairments result from lesion location, size and cortical reorganization.(22, 38,
39) A higher false positive rate, alpha=0.1, was accepted to generate hypotheses
for future research. We found tDCS stimulation had a positive effect on fastest
comfortable gait speed, paretic step ratio during self-selected and fastest
comfortable speeds, and paretic propulsion at self-selected speeds. We also
observed the “best montage” often varied for each measure of walking
performance (Table 3) within individuals. The lack of a specific pattern lends
support to the idea that “one-size does not fit all” in tDCS prescription.(40)
Investigators should consider that different electrode montages may impact
different features of walking performance on an individual level based on gait
speed, clinical features like stroke chronicity(40), or presence, type and degree of
interhemispheric imbalance. It is important to note we did not investigate the
reproducibility and robustness of our observed effects (i.e., would the electrode
configuration that shows the best result be the same under a second test). Nor
did we have a large enough sample to examine whether clinical performance or
baseline walking performance could predict tDCS response. Previous
investigations have demonstrated the reproducibility and benefit of personalized
tDCS electrode montage in language rehabilitation.(41, 42) Our results suggest
this effect should also be tested in walking rehabilitation and whether markers of
clinical or baseline walking performance predict participant response.
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Investigators should screen individuals for inter-hemispheric imbalances using
TMS in addition to prioritizing assessment of neurophysiological effects from
tDCS to establish associations between stimulation and neural
pathophysiological changes.
Our exploratory comparison of the effect of tDCS on muscle activation
patterns offers one potential window into the mechanisms by which different
tDCS electrode configurations may influence walking. Many participants with
more severe impairment (ie, 2 or 3 modules) were able to move away from mass
flexion and extension muscle activation patterns in response to tDCS. We
hypothesize that tDCS can modulate the cortex to enhance voluntary muscle
activity during walking for some individuals. This is supported by evidence that
tDCS can increase force production in lower extremity muscles and helps explain
the association we found between paretic propulsion and improved muscle
activation patterns.(22, 29, 43) The individual variability we observed could be
explained by the fact that walking is also influenced by subcortical structures.
Thus, individuals with more severe cortical impairments may have a greater
response to tDCS. However, like our findings related to the best response
condition, we cannot be certain that we have captured a true effect since we did
not test the reproducibility of our findings and we have a very small sample for
each module number at baseline limiting our statistical power. We recommend
that more research examine the effects of tDCS on muscle activation patterns
since they can provide a mechanistic understanding for biomechanical changes
in task performance.(44)
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Finally, there are a few methodological choices in our design that may
have impacted the results. First, we are unable to know whether current was
shunted during the dual montage experimental condition. It is possible that
current may have crossed between the two cephalic pads creating a different
stimulation environment than hypothesized. Second, our washout period of 48
hours may not have been sufficiently long enough. There is precedence for a 48hour washout in post-stroke tDCS literature(3, 11) but no formal investigation into
the optimal length of time has been done and recent recommendations call for a
minimum 1-week period(26). Lastly, the robust response to sham for many
subjects suggests that twenty minutes of walking may provide a neuromodulating
effect as potent as a single tDCS session and appears to have been an active
ingredient in our experiment. Ojardias et. al.(21) saw a similar response to
walking on walking performance in individuals post-stroke after examining a
single session of tDCS and there is recent evidence to support that moderate
intensity aerobic activity can increase neurophysiological markers of corticospinal
excitability.(45-47) An intriguing question is whether the increase in corticospinal
excitability that accompanies tDCS has a similar mechanism to the increase with
walking practice, and whether the effects are additive when the two stimuli are
combined. Future research should be designed to further investigate the effects
of walking practice on excitability, with and without concomitant tDCS.
In summary, our observation that individuals may have an optimal tDCS
electrode montage to elicit improvements in walking performance is perhaps the
most important finding of this study. The possibility that individuals post-stroke
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likely need personalized stimulation parameters has important implications for
hypothesis generation and future tDCS studies attempting to optimize tDCS
prescription. It is imperative for investigators to employ research methods to best
understand how electrode placement will impact walking performance
considering clinical presentation corticomotor response, neuroanatomy and
tractography to address heterogeneity in participant response to tDCS.

199
REFERENCES:
1.

Mayo NE, Wood-Dauphinee S, Cote R, Durcan L, Carlton J. Activity,

participation, and quality of life 6 months poststroke. Archives of physical
medicine and rehabilitation. 2002 Aug;83(8):1035-42.
2.

Madhavan S, Stinear JW. Focal and bi-directional modulation of lower

limb motor cortex using anodal transcranial direct current stimulation. Brain
stimulation. 2010 Jan;3(1):42.
3.

Madhavan S, Weber KA, 2nd, Stinear JW. Non-invasive brain stimulation

enhances fine motor control of the hemiparetic ankle: implications for
rehabilitation. Exp Brain Res. 2011 Mar;209(1):9-17.
4.

Schlaug G, Renga V, Nair D. Transcranial direct current stimulation in

stroke recovery. Arch Neurol. 2008 Dec;65(12):1571-6.
5.

Woods AJ, Antal A, Bikson M, Boggio PS, Brunoni AR, Celnik P, et al. A

technical guide to tDCS, and related non-invasive brain stimulation tools. Clin
Neurophysiol. 2016 Feb;127(2):1031-48.
6.

Nowak DA, Grefkes C, Ameli M, Fink GR. Interhemispheric competition

after stroke: brain stimulation to enhance recovery of function of the affected
hand. Neurorehabil Neural Repair. 2009 Sep;23(7):641-56.
7.

Hummel F, Cohen LG. Improvement of motor function with noninvasive

cortical stimulation in a patient with chronic stroke. Neurorehabilitation and neural
repair. 2005 Mar;19(1):14-9.

200
8.

Jeffery DT, Norton JA, Roy FD, Gorassini MA. Effects of transcranial

direct current stimulation on the excitability of the leg motor cortex. Experimental
Brain Research. 2007 2007/09/01;182(2):281-7.
9.

Tatemoto T, Yamaguchi T, Otaka Y, Kondo K, Tanaka S, editors. Anodal

Transcranial Direct Current Stimulation over the Lower Limb Motor Cortex
Increases the Cortical Excitability with Extracephalic Reference Electrodes. 2013;
Berlin, Heidelberg: Springer Berlin Heidelberg.
10.

Reis J, Fritsch B. Modulation of motor performance and motor learning by

transcranial direct current stimulation. Current opinion in neurology. 2011
Dec;24(6):590-6.
11.

Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, et al.

Transcranial direct current stimulation of the unaffected hemisphere in stroke
patients. Neuroreport. 2005 Sep 28;16(14):1551-5.
12.

Boggio PS, Nunes A, Rigonatti SP, Nitsche MA, Pascual-Leone A, Fregni

F. Repeated sessions of noninvasive brain DC stimulation is associated with
motor function improvement in stroke patients. Restorative neurology and
neuroscience. 2007;25(2):123-9.
13.

Kim DY, Lim JY, Kang EK, You DS, Oh MK, Oh BM, et al. Effect of

transcranial direct current stimulation on motor recovery in patients with subacute
stroke. American journal of physical medicine & rehabilitation / Association of
Academic Physiatrists. 2010 Nov;89(11):879-86.

201
14.

Fridriksson J, Basilakos A, Stark BC, Rorden C, Elm J, Gottfried M, et al.

Transcranial direct current stimulation to treat aphasia: Longitudinal analysis of a
randomized controlled trial. Brain stimulation. 2019 Jan - Feb;12(1):190-1.
15.

Fridriksson J, Rorden C, Elm J, Sen S, George MS, Bonilha L.

Transcranial Direct Current Stimulation vs Sham Stimulation to Treat Aphasia
After Stroke: A Randomized Clinical Trial. JAMA neurology. 2018 Dec
1;75(12):1470-6.
16.

Li Y, Fan J, Yang J, He C, Li S. Effects of transcranial direct current

stimulation on walking ability after stroke: A systematic review and meta-analysis.
Restorative neurology and neuroscience. 2018;36(1):59-71.
17.

Lefaucheur J-P, Antal A, Ayache SS, Benninger DH, Brunelin J,

Cogiamanian F, et al. Evidence-based guidelines on the therapeutic use of
transcranial direct current stimulation (tDCS). Clinical Neurophysiology. 2017
2017/01/01/;128(1):56-92.
18.

Vaz PG, Salazar A, Stein C, Marchese RR, Lukrafka JL, Plentz RDM, et

al. Noninvasive brain stimulation combined with other therapies improves gait
speed after stroke: a systematic review and meta-analysis. Top Stroke Rehabil.
2019 Apr;26(3):201-13.
19.

Lefebvre S, Liew SL. Anatomical Parameters of tDCS to Modulate the

Motor System after Stroke: A Review. Frontiers in neurology. 2017;8:29.
20.

Tahtis V, Kaski D, Seemungal BM. The effect of single session bi-cephalic

transcranial direct current stimulation on gait performance in sub-acute stroke: A
pilot study. Restorative neurology and neuroscience. 2014;32(4):527-32.

202
21.

Ojardias E, Aze OD, Luneau D, Mednieks J, Condemine A, Rimaud D, et

al. The Effects of Anodal Transcranial Direct Current Stimulation on the Walking
Performance of Chronic Hemiplegic Patients. Neuromodulation : journal of the
International Neuromodulation Society. 2019 May 23.
22.

van Asseldonk EH, Boonstra TA. Transcranial Direct Current Stimulation

of the Leg Motor Cortex Enhances Coordinated Motor Output During Walking
With a Large Inter-Individual Variability. Brain stimulation. 2016 MarApr;9(2):182-90.
23.

Fugl-Meyer A, Jaasko L, Leyman I, Olsson S, Seglind S. The post-stroke

hemiplegic patient: a method of evaluation of physical performance.
Scandinavian journal of rehabilitation medicine. 1975;7:13-31.
24.

Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in

the elderly: validation of an instrument. Canadian journal of public health Revue
canadienne de sante publique. 1992 Jul-Aug;83 Suppl 2:S7-11.
25.

Shumway-Cook A, Woollacott M. Motor Control: Theory and Practical

Applications. Philadelphia: Lippincott Williams and Wilkins; 2001.
26.

Thair H, Holloway AL, Newport R, Smith AD. Transcranial Direct Current

Stimulation (tDCS): A Beginner's Guide for Design and Implementation. Frontiers
in neuroscience. 2017;11:641.
27.

Noetscher GM, Yanamadala J, Makarov SN, Pascual-Leone A.

Comparison of cephalic and extracephalic montages for transcranial direct
current stimulation--a numerical study. IEEE transactions on bio-medical
engineering. 2014 Sep;61(9):2488-98.

203
28.

Angius L, Pageaux B, Hopker J, Marcora SM, Mauger AR. Transcranial

direct current stimulation improves isometric time to exhaustion of the knee
extensors. Neuroscience. 2016 Dec 17;339:363-75.
29.

Tanaka S, Takeda K, Otaka Y, Kita K, Osu R, Honda M, et al. Single

session of transcranial direct current stimulation transiently increases knee
extensor force in patients with hemiparetic stroke. Neurorehabilitation and neural
repair. 2011 Jul-Aug;25(6):565-9.
30.

Lamontagne A, Fung J. Faster is better: implications for speed-intensive

gait training after stroke. Stroke. 2004 Nov;35(11):2543-8.
31.

Sullivan KJ, Knowlton BJ, Dobkin BH. Step training with body weight

support: effect of treadmill speed and practice paradigms on poststroke
locomotor recovery. Archives of physical medicine and rehabilitation. 2002
May;83(5):683-91.
32.

Bowden MG, Balasubramanian CK, Neptune RR, Kautz SA. Anterior-

posterior ground reaction forces as a measure of paretic leg contribution in
hemiparetic walking. Stroke. 2006 Mar;37(3):872-6.
33.

Balasubramanian CK, Bowden MG, Neptune RR, Kautz SA. Relationship

between step length asymmetry and walking performance in subjects with
chronic hemiparesis. Archives of physical medicine and rehabilitation. 2007
Jan;88(1):43-9.
34.

Lee DD, Seung HS. Learning the parts of objects by non-negative matrix

factorization. Nature. 1999 Oct 21;401(6755):788-91.

204
35.

Ting LH, Macpherson JM. A limited set of muscle synergies for force

control during a postural task. J Neurophysiol. 2005 Jan;93(1):609-13.
36.

Hermens HJ, Freriks B, Disselhorst-Klug C, Rau G. Development of

recommendations for SEMG sensors and sensor placement procedures. J
Electromyogr Kinesiol. 2000 Oct;10(5):361-74.
37.

Clark DJ, Subramanian S, Neptune RR, SA K, editors. Fewer basic

activation patterns account for lower extremity EMG during walking in adults
post-stroke compared to healthy controls. Neural Control of Movement Annual
Meeting; 2008; Naples, FL.
38.

Jones TA. Motor compensation and its effects on neural reorganization

after stroke. Nature reviews Neuroscience. 2017 May;18(5):267-80.
39.

Lefebvre S, Dricot L, Laloux P, Gradkowski W, Desfontaines P, Evrard F,

et al. Neural substrates underlying stimulation-enhanced motor skill learning after
stroke. Brain : a journal of neurology. 2015 Jan;138(Pt 1):149-63.
40.

McCambridge AB, Stinear JW, Byblow WD. Revisiting interhemispheric

imbalance in chronic stroke: A tDCS study. Clin Neurophysiol. 2018
Jan;129(1):42-50.
41.

Shah-Basak PP, Norise C, Garcia G, Torres J, Faseyitan O, Hamilton RH.

Individualized treatment with transcranial direct current stimulation in patients
with chronic non-fluent aphasia due to stroke. Front Hum Neurosci. 2015;9:201.
42.

Sebastian R, Tsapkini K, Tippett DC. Transcranial direct current

stimulation in post stroke aphasia and primary progressive aphasia: Current

205
knowledge and future clinical applications. NeuroRehabilitation. 2016;39(1):14152.
43.

Sohn MK, Jee SJ, Kim YW. Effect of transcranial direct current stimulation

on postural stability and lower extremity strength in hemiplegic stroke patients.
Annals of rehabilitation medicine. 2013 Dec;37(6):759-65.
44.

Bowden MG, Clark DJ, Kautz SA. Evaluation of abnormal synergy

patterns poststroke: relationship of the Fugl-Meyer Assessment to hemiparetic
locomotion. Neurorehabil Neural Repair. 2010 May;24(4):328-37.
45.

Garnier YM, Lepers R, Stapley PJ, Papaxanthis C, Paizis C. Changes in

cortico-spinal excitability following uphill versus downhill treadmill exercise.
Behavioural brain research. 2017 Jan 15;317:242-50.
46.

Bonnard M, Camus M, Coyle T, Pailhous J. Task-induced modulation of

motor evoked potentials in upper-leg muscles during human gait: a TMS study.
The European journal of neuroscience. 2002 Dec;16(11):2225-30.
47.

Yamazaki Y, Sato D, Yamashiro K, Nakano S, Onishi H, Maruyama A.

Acute Low-Intensity Aerobic Exercise Modulates Intracortical Inhibitory and
Excitatory Circuits in an Exercised and a Non-exercised Muscle in the Primary
Motor Cortex. Frontiers in physiology. 2019;10:1361.

206
Figure 1: Timeline of Experimental Procedures

Participants completed clinical testing during enrollment. For each of the four
experimental sessions (3 active and one sham), participants completed pretesting followed by active tDCS or sham stimulation with treadmill walking and
concluded with post-testing.
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Figure 2: Diagram of experimental tDCS montages

Excitatory Montage: Anode pad was placed over the target ipsilesional M1 leg
area, reference pad was placed on the ipsilateral shoulder
Inhibitory Montage: Cathode pad was placed over the target contralesional M1
leg area, reference pad was placed on the ipsilateral shoulder.
Dual Montage: Combination of the Excitatory and Inhibitory montages using 2
tDCS units with one delivering the excitatory (anode placed over the target
ipsilesional M1 leg area) and the other inhibitory (cathode pad was placed over
the target contralesional M1 leg area) currents.

In each montage the cephalic pad was placed 1cm lateral to the vertex and 1 cm
posterior to an imaginary line between the tragi. This created a 2cm gap between
cephalic electrodes in the Dual montage.
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Table 1: Participant Demographics
n
Age (years)
mean (SD) [range]
Sex (male)
frequency (%)
Hemiparetic side (right)
frequency (%)
Chronicity (months)
mean (SD) [range]
FM-Total LE
mean (SD) [range]
FM-Synergy
mean (SD) [range]
Dynamic Gait Index
mean (SD) [range]
Berg Balance Scale
mean (SD) [range]
Gait Speed
(self-selected) (m/s)
mean (SD) [range]
Paretic Step Ratio
mean (SD) [range]
Modules
mean (SD) [range]

Descriptive Statistics

16

59 (11.5) [30-77]

16

11/16 (68.8%)

16

9/16 (56.3%)

16

54.56 (76.5) [10-325]

16

23.94 (5.78) [13-32]

16

15.56 (4.15) [8-21]

15

16 (4.55) [7-22]

11

46.91 (8.94) [25-55]

16

0.82 (0.33) [0.23-1.43]

16

0.51(0.06) [0.37-0.63]

16

2.94 (0.85) [2-4]
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Table 2: Descriptive statistics for change scores as a result of each tDCS
electrode montage and sham stimulation

SelfSelected

Fastest
Comfortable

Gait Speed
m/s
Paretic
Step Ratio
Paretic
Propulsion
Gait Speed
m/s
Paretic
Step Ratio
Paretic
Propulsion

Sham
0.086
(0.132)
0.005
(0.012)
0.015
(0.061)
0.059
(0.051)
-0.003
(0.012)
0.012
(0.056)

tDCS Experimental Condition
Excitatory
Inhibitory
Dual
0.043
0.068
0.085
(0.128)
(0.092)
(0.109)
0.009
0.003
0.002
(0.022)
(0.032) ǂ
(0.032)
0.006
0.027
0.023
(0.069)
(0.043)
(0.074)
0.042
0.020
0.036
(0.134)
(0.081)
(0.100) ǂ
-0.000
-0.005
-0.020
(0.017)
(0.019)
(0.0.28) ǂ
-0.003
-0.007
0.005
(0.041) ǂ
(0.048) ǂ
(0.040)

Statistics are presented as mean (standard deviation)
ǂ Indicates median (interquartile range)
Gait speed was calculated from overground walking trials.
Paretic Step Ratio and Paretic Propulsion were calculated from treadmill walking
trials.
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Table 3: Individual variability in response to tDCS stimulation based on electrode
montage

Self-Selected Speed
Paretic
Step
Ratio

Participant Gait
Number
Speed

1
2
3
4
6
7
8
9
10
11
12
13
15
16
17
18

2
2
2
3
3
3
2
3
3
3
3
1
1
3
1
3

Fastest Comfortable Speed
Paretic
Step
Ratio

Paretic
Gait
Propulsion Speed

1
3
1
1
2
3
2
3
3
1
2
1
1
2
1
1

3
1
2
2
1
3
2
2
2
×
2
3
1
1
2
3

1
2
1
3
3
1
2
3
3
1
1
2
3
2
1
1

Paretic
Propulsion

2
1
1
2
3
1
2
3
1
3
1
3
1
1
2
1

2
3
3
1
1
1
1
3
1
×
3
1
3
1
2
2

Numeric codes for each variable indicate the montage (electrode placement and
stimulation parameters) that elicited the best response for each participant.
1 = Excitatory montage (color = light orange)
2 = Inhibitory montage (color = light blue)
3 = Dual montage (color = white)
× Missing data due to poor GRF quality during data collection.
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Table 4: Descriptive statistics for change scores comparing the effect of tDCS
compared to sham stimulation using a participant’s best response to each of the
three electrode montages

Self-Selected

Fastest
Comfortable

Sham

Pooled Best
Response to tDCS

Gait Speed
m/s

0.086 (0.132)

0.136 (0.106)

Paretic Step
Ratio

0.005 (0.019) ǂ

0.017 (0.023) ǂ **

Paretic
Propulsion

0.015 (0.061)

0.051 (0.049) *

Gait Speed
m/s

0.059 (0.051)

0.114 (0.111) *

Paretic Step
Ratio

-0.003 (0.012)

0.007 (0.019) *

Paretic
Propulsion

0.002 (0.068) ǂ

0.026 (0.053) ǂ

** Indicates statistical significance at p<0.05.
* Indicates statistical significance at p<0.10.
Statistics are presented as mean (standard deviation)
ǂ Indicates median (interquartile range)
Pooled Best Response was created by pooling each participant’s best response
to any of the tDCS electrode montages for a given variable.
Gait speed was calculated from overground walking trials.
Paretic Step Ratio and Paretic Propulsion were calculated from treadmill walking
trials.
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Table 5: Individual variability in muscle activation pattern response to tDCS
stimulation

Change in Module Number
Participant
Number
1
7
11
12
16
17
3
4
8
10
15
2
6
9
13
18

Baseline
Module
Excitatory
Number
2
0
2
1
2
0
2
0
2
1
2
1
3
0
3
1
3
0
3
0
3
0
4
0
4
0
4
0
4
0
4
0

Inhibitory

Dual

Sham

1
1
0
2
0
1
1
0
0
0
1
0
0
×
0
-1

2
0
0
1
1
1
0
1
0
0
1
0
0
-1
0
0

2
2
0
2
0
1
1
1
1
-1
1
0
×
-1
0
0

× Missing data due to poor EMG quality during data collection.
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CHAPTER 5
CONCLUSION

5.1 CONCLUSION
Personalized rehabilitation holds the promise of improved health
outcomes because it can account for individual differences between people
(Denny & Collins, 2021). Addressing individual differences has been a prominent
barrier for advances in stroke rehabilitation that has typically been relegated to a
“one size fits all” approach because of the lack of evidence-based tools for
personalized rehabilitation (Cramer et al., 2017). As stroke rehabilitation
embraces personalized approaches clinicians and researchers should use and
generate evidence that addresses individual variability to improve outcomes by
providing the right treatment to the right person at the right time. The work in this
dissertation provides a body of evidence for personalized stroke rehabilitation by
addressing three research needs identified by StrokeNet for understanding
individual variability.
Part I was designed to show the benefit of standardized outcome
measurement on personalized stroke rehabilitation. Our work demonstrated how
applications of item-psychometrics can give meaningfulness to standard outcome
measurement scores. We used an ability map for the FGA to show how clinicians
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can use information about item difficulty hierarchies and patient response
patterns to inform treatment planning and plan of care development for an
individual patient. We also used item-level psychometrics generated by a Rasch
analysis to demonstrate how error is different for different portions of a
measurement scale and how that information can be used to evaluate change
more precisely at the individual-level.
Part II was an initial step towards identifying a biomarker for walkingspecific motor control recovery. Biomarkers need to be linked with underlying
mechanisms for pathophysiology. We showed how modules, a measure of
muscle coordination (i.e., walking-specific motor control) during walking, is
strongly associated with observable biomechanical measures that are related to
key functional tasks for successful walking. Our findings suggests that modules
may have an expressed biomechanical signature of that could be used as a
biomarker for walking-specific motor control recovery. This is important for stroke
rehabilitation because modules share a strong association with neural damage
and differences in motor recovery among individuals.
Part III demonstrated that more emphasis should be placed on evaluating
how manipulation of treatment parameters will influence individual treatment
response. We showed that the type of tDCS montage may to be a source of the
high individual variability in treatment response to non-invasive brain stimulation.
Our findings illustrate the importance of examining treatment parameters to
provide the best evidence for individualized prescription.
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5.2 FUTURE DIRECTIONS
The collection of studies in this dissertation have provided a “road map”
for future studies in the areas of standardized measurement, biomarker
development, and evaluating variability in treatment response.
Many of the applications from item response theory have yet to be tested
in a pragmatic way. We have demonstrated how ability maps can inform clinical
decision making to elevate personalized rehabilitation, but future studies need to
examine whether using ability maps have an impact on clinical outcomes. Future
pragmatic trials could be designed to evaluate stroke rehabilitation outcomes
between traditional practice and a cohort using ability maps. Alongside this study,
investigators could survey physical therapists to determine whether ability maps
addressed many of the previously reported barriers to standardized outcome
assessment that we theorized the maps would. Based on our work in Part I, we
make the argument that cMDCs will improve clinical care by preventing
misclassification of patients’ change status. We also argue that cMDCs would
reduce sample size needs and prevent Type II errors in research studies.
However, more work is needed to determine whether both would be the case.
We recommend using simulation studies to examine the differences between the
MDC and cMDC on sample size and Type II error rates, as well as
retrospectively examine change data from large trials to see what proportion of
individuals would have been misclassified under the cMDC approach.
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Biomarkers for stroke recovery hold a great deal of promise. However, it
has been difficult to identify biomarkers for functional tasks, like walking. Our
findings in Part II take an important step towards identifying a biomarker for
stroke recovery of walking-specific motor control using modules and
biomechanical variables. Our findings provided more evidence to strengthen the
theory that modules share a mechanistic link with observable, measurable
biomechanical variables during healthy walking. However, we limited ourselves
to sagittal plane mechanics and found that anterior-posterior leg angle and leg
length only partially captured swing mechanics. Future work should attempt to
expand on the measures we used in our design to create a more comprehensive
biomechanical signature for each module. Specific examples include expanding
the analyses to include frontal plane biomechanical variables and measures of
leg velocity or acceleration to better capture swing phase mechanics.
Biomechanical variables have always held interest as a potential marker for
stroke walking performance because deviations in movement patterns can often
be observed and used as treatment targets in rehabilitation. However, there is
not a well understood framework for linking biomechanics back to the level of
stroke pathology that would help differentiate individuals for more personalized
treatment. Modules are a potential way to solve this problem because they
capture individual differences in motor recovery linked with mechanisms of
underlying neural pathology. Once a comprehensive biomechanical signature is
established for each module, future work that can explore module and
biomechanical variable associations in stroke pathology. Specifically, studies can
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examine how changes in modules post-stroke are related to changes in
biomechanical signatures and whether altered signatures can be predictive of
modules or walking-specific motor control. Lastly, future prospective studies can
examine whether treatments designed to treat abnormal biomechanical
signatures result in changes to modules.
Finally, there is still more work needed in the field of intervention
prescription for stroke rehabilitation. Individual variability in treatment response
continues to impede progress for tDCS to be used regularly in clinical practice.
Our findings demonstrate that individual variability could be a result of limited
knowledge about how manipulation of treatment parameters influence outcomes.
Future studies should examine the effects of individual parameters on outcomes
and attempt to replicate those effects by re-treating or testing individuals based
on findings from a test period. For example, with respect to electrode montage in
tDCS, future studies would have a second arm of the study where individuals
received their “optimal” prescription and evaluate whether their “optimal”
prescription reproduced their previous results. Secondly, our results point to the
importance for intervention prescription to have a theoretical mechanistic link to
pathology that can be tested. This is important because a common framework for
relating individual stroke neuropathology to recommended interventions is still a
bit disparate. We theorized pad placement montages in our design based on
predicted neural damage, however, our study would have been strengthened by
testing our underlying hypotheses for each montage. Measures of neural
physiology and brain imaging could have been used to test whether our
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proposed neuropathology was present and whether the tDCS prescription has an
impact on the underlying neuropathology. Another potential direction is to
examine the effect of tDCS on impairment measures that reflect changes in
individual neuropathology. This can be particularly useful for clinicians because
impairment measures may reveal a phenotypic expression of neuropathology
that serves to identify treatment targets for a specific individual. Our study
examined the effects of tDCS on modules which is an impairment measure for
walking-specific motor control. Our results suggested that tDCS may have an
acute effect on modules and that treatment response may be dependent on
individual variability in walking-specific motor control impairment. However, the
robustness of our findings needs to be investigated. Still, modules may serve as
an impairment measure that can be used to understand variability between
individuals and inform treatment prescription. Future studies should keep this
conceptual model of approaching study design for interventions to strengthen our
ability to differential between individuals and personalize treatment prescription.
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